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1 SUMMARY 
RecQ DNA helicases are involved in processing of complex DNA structures 
arising during DNA metabolism to prevent aberrant mitotic recombination. 
Inherited defects in three of the five human RecQ helicases give rise to 
cancer predisposition syndromes. RECQ5 has not been associated with 
human disease. However, deletion of the Recq5 gene in mice results in 
cancer susceptibility. How RECQ5 could act as a tumor suppressor is not yet 
clear. Recent findings suggest that RECQ5 has a role in DNA replication and 
homologous recombination. RECQ5 associates with the replication machinery 
and accumulates at sites of stalled replication forks and DNA double-strand 
breaks. In addition, RECQ5 interacts physically with the RAD51 recombinase 
and possesses the ability to disrupt RAD51 presynaptic filaments. 
 In a first study, we analyzed the activity of RECQ5 helicase on DNA 
structures that resemble stalled replication forks. RECQ5 was found to 
convert M13-based forked DNA substrates with a long leading-strand gap into 
four-way junctions as revealed by restriction-enzyme digestion of the reaction 
products. However, these structures were not sensitive to cleavage by the 
Holliday-junction resolvase RusA. These controversial findings and the 
observed low extent of RECQ5-promoted fork-regression reaction argue 
against a role for RECQ5 in the repair of stalled replication forks by template 
switching. 
 In a second study, we explored the mechanism underlying RECQ5-
mediated disruption of RAD51 presynaptic filaments. We investigated whether 
the observed physical interaction between RECQ5 and RAD51 is required for 
RECQ5-mediated displacement of RAD51 from ssDNA. To do so, we mapped 
precisely the RAD51-interaction site on RECQ5 and tested RECQ5 mutants 
that fail to interact with RAD51 for the ability to displace RAD51 from ssDNA 
in a topoisomerase-linked RAD51-trap assay. We found that direct RAD51 
binding enhances the RAD51 filament-disruption activity of RECQ5 but it is 
not essential for it. In addition, we found that the helicase core fragment of 
RECQ5 was not able to displace RAD51 from ssDNA, suggesting a 
mechanistic difference between DNA unwinding and protein-DNA complex-
disruption activity of RECQ5. 
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2 ZUSAMMENFASSUNG 
RecQ DNA Helikasen sind in die Verarbeitung von komplexen DNA 
Strukturen involviert, die während dem DNA Metabolismus entstehen und 
verhindern unangemessene mitotische Rekombination.  
Vererbte Gendefekte in drei der fünf humanen RecQ Helikasen verursachen 
Krebsprädispositions-Syndrome. RECQ5 ist nicht assoziiert mit einer 
Erkrankung beim Menschen. Ein inaktiviertes Recq5 Gen in der Maus 
verursacht hingegen eine Disposition für Krebserkankungen. Wie RECQ5 als 
Tumorsuppressor agiern könnte, ist bis jetzt nicht klar. Neuere Daten weisen 
auf eine Funktion von RECQ5 in der DNA Replikation und homologer 
Rekombination hin. RECQ5 ist assoziiert mit der Replikationsmaschinerie und 
akkumuliert an blockierten Replikationsgabeln und DNA Doppel-
strangbrüchen. Zusätzlich interagiert RECQ5 direkt mit der RAD51 
Rekombinase und besitzt die Fähigkeit präsynaptische RAD51 Filamente zu 
zerlegen. 
Im ersten Teil der Studie untersuchten wir die RECQ5 Helikase Aktivität auf 
M13-basierten DNA Strukturen, die blockierten Replikationsgabeln glichen. 
Durch Restriktionsenzym-Verdau der Reaktionsprodukte wurde sichtbar 
gemacht, dass RECQ5 gabelförmige DNA Substrate mit einer grossen Lücke 
im Folgestrang in kreuzförmige DNA Strukturen umwandeln konnte. Diese 
Strukturen wurden aber nicht vom Holliday-Struktur spezifischen Enzym RusA 
geschnitten. Diese kontroversen Ergebnisse und das geringe Ausmass der 
Regressionsreaktion katalysiert durch RECQ5 sprechen gegen eine Funktion 
von RECQ5 in der Reparatur von blockierten Replikationsgabeln durch einen 
Matrizenwechsel-Mechanismus. 
Im zweiten Teil dieser Studie untersuchten wir den Mechanismus durch den 
RECQ5 präsynaptische RAD51 Filamente zerlegt. Wir untersuchten, ob die 
beobachtete direkte Interaktion zwischen RAD51 und RECQ5 dazu notwendig 
ist. Dafür kartierten wir die präzise Interaktionsstelle von RAD51 auf RECQ5. 
RECQ5 Mutanten, die nicht mit RAD51 interagieren konnten, wurden dann in 
einem Topoisomerase-basierten RAD51 Assay getestet auf ihre Fähigkeit 
RAD51 von einzelsträngiger DNA zu entfernen. Wir konnten zeigen, dass 
direkte RAD51-RECQ5 Interaktion stimulierend auf das Entfernen von RAD51 
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Filamenten durch RECQ5 wirkt, aber nicht notwendig dafür ist. Zusätzlich 
beobachteten wir, dass das Helikase-core Fragment von RECQ5 nicht in der 
Lage war RAD51 von einzelsträngiger DNA zu entfernen, was auf einen 
mechanistischen Unterschied zwischen dem Entwinden von DNA und dem 
Entfernen von an DNA gebundene Proteine durch RECQ5 hindeutet. 
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3 INTRODUCTION 
 
3.1 Maintenance of genome integrity and suppression of 
tumorigenesis 
Numerous alterations in the genome of cancer cells are found. The spectrum 
ranges from point mutations, small insertions and deletions of nucleotides (nt) 
to gross chromosomal aberrations that can result from breakage and rejoining 
of chromosomes and aneuploidy, the condition in which a cell has extra or 
missing chromosomes. In addition, epigenetic changes may contribute to the 
development of neoplasia (1). In this process, changes in gene expression 
are not accompanied by changes in DNA sequence but arise from covalent 
modifications of histones or other chromatin components and changes in DNA 
cytosine-methylation patterns. 
 That cancer is an extremely heterogeneous disease becomes also 
obvious by the large number of genes identified to be causally implicated in 
tumorigenesis. In an ongoing effort to catalogue those cancer critical genes 
(cancer gene) in humans, 291 genes were reported in an original census 
conducted in 2004 (2), and now, this list contains a collection of over 400 
genes (www.sanger.ac.uk/genetics/CGP/Census/). Despite this variability, 
cancer cell behavior on molecular basis can be explained by a relatively small 
number of events leading to deregulation in crucial cellular pathways (3-5). It 
is proposed that mutations in a minimum of four to seven cancer genes are 
sufficient to transform a cell and alter its properties in proliferation, 
differentiation, and survival to confer growth advantage. However, it might be 
rare that cancer develops because of only four to seven mutations that hit or 
deregulate exactly a set of cancer genes in the huge human genome with 
approximately 23.000 protein-coding genes 
(www.ensembl.org/Homo_sapiens/Info/Index). It does not astonish that in 
cancer typically much higher number of mutations are found. Analysis of 
breast and colorectal cancers revealed that individual tumors accumulate an 
average of approximately 90 mutant protein-coding genes, most of it 
accidental passenger or bystander mutations that are not involved in 
tumorigenesis (6). Dysfunction of genes involved in genome maintenance is 
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implicated in increased mutation rate and an important driving force for tumor 
progression. This phenomenon underlies the accelerated tumor progression 
observed in patients with hereditary nonpolyposis colorectal cancer (HNPCC). 
Loss of post-replicative mismatch repair (MMR) leads to an increased rate of 
somatic mutations, which, in turn, might increase the likelihood of cancer 
critical growth-control genes being mutated (7,8). HNPCC is a rare cancer 
predisposition syndrome due to germ line mutations in key MMR genes. In the 
cancer gene catalogue, 73 genes are reported to predispose carriers to 
cancer when mutated in the germ line 
(www.sanger.ac.uk/genetics/CGP/Census/germline_mutation.shtml). In this 
catalogue, genes associated with DNA maintenance and repair are clearly 
overrepresented, which indicates the importance of functional genome 
surveillance system to suppress tumorigenesis (Tab.1). Three members of the 
RecQ family of DNA helicases (BLM, WRN, RECQL4) are also among those 
genes that cause, if mutated, hereditary cancer syndromes. The focus of my 
thesis is on a further member of this helicase family, RECQ5, and its role in 
DNA metabolism.  
 
3.2 DNA damage and DNA repair 
Efficient detection and repair of DNA damage is particularly important for 
dividing cells to transmit the correct complement of genetic material to their 
progeny. DNA damage is not a rare event. It occurs at high frequency also 
under normal physiological conditions. For example, it has been estimated 
that loss of purine bases due to spontaneous hydrolysis of N-glycosyl bonds 
is in the order of 104 events per day for a mammalian cell (9). Other frequent 
DNA lesions, caused by endogenous sources, are deamination and 
methylation of bases and oxidative damage of bases and sugars in the DNA 
backbone (Fig. 1) (10). Furthermore, during DNA replication the cell has to 
cope with misincorporated bases (11), nicked DNA, single-stranded (ss) gaps 
and double-stand breaks (DSBs). In addition, environmental agents, such as 
UV light, ionizing radiation, and numerous genotoxic chemicals including 
alkylating agents and polycyclic aromatic hydrocarbons, can cause alterations 
in DNA structure (12). 
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Table 1 
Cancer syndromes associated with defect in DNA maintenance and repair. Table 1 lists 
the genes of the germline mutated cancer gene catalogue 
(www.sanger.ac.uk/genetics/CGP/Census/germline_mutation.shtml) that are implicated in 
genome surveillance and stability. The listed cancer syndromes are all recessive disorders. 
Carriers are predisposed to develop cancer because of one defective allele and loss of the 
second allele is usually observed in tumor cells. In addition, associated with several of these 
germ line mutations are pathologies other than cancer. AML, acute myelogenous leukemia; 
CNS, central nervous system; NHL, non-Hodgkin lymphoma. 
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 Cells have evolved pathways to prevent genome from excessive 
mutagenesis. Most of these pathways are conserved through evolution. In 
bacteria, yeast and vertebrates similar sets of molecular players are found 
that detect DNA lesions and repair or tolerate them. Alternatively, multicellular 
organisms can activate a programmed cell-death process to eliminate cells 
with severely damaged DNA (13). 
 Five major DNA repair mechanisms have evolved: (i) direct repair, (ii) 
base excision repair (BER), (14) nucleotide excision repair (NER), (iv) 
mismatch repair (MMR), and (v) DSB repair (12,15). DSBs can be repaired 
either by non-homologous end joining (NHEJ) or homologous recombination 
(HR). Since one topic of this thesis deals with the regulatory role of RECQ5 
helicase in HR, the HR pathway is described in detail in chapter 3.3. The 
other repair systems are described here only briefly with emphasis on the 
overall mechanism of the DNA repair reaction.  
 Direct repair is catalyzed by highly specific repair proteins, which 
recognize a particular base modification and reverse it in a single-step 
reaction. In humans, the enzyme O6-methylguanine-DNA methyltransferase 
(MGMT or AGT) corrects O6-methylated guanine by transferring the methyl 
group to a cysteine residue in its active site (16,17). In BER, NER and MMR, 
DNA lesions are excised and the original DNA sequence is restored by DNA 
synthesis using the intact opposite strand as template. The remaining nick is 
then sealed by DNA ligases. BER is a multi-step process that is initiated by 
DNA glycosylases. These enzymes recognize specific types of modified 
bases and remove them by cleavage of the N-glycosidic bond. Abasic sites 
are then processed by an apyrimidinic/apurinic (AP) endonuclease. In 
humans, eight different DNA-glycosylases with partially overlapping substrate 
specificities have been described (18). NER is an elaborate repair mechanism 
where more than 30 proteins are involved and function in multi-protein 
complexes (19). DNA damage is rather indirectly recognized through 
distortion of the DNA helix structure (20). Such distortions can occur by bulky 
DNA adducts or by UV induced crosslinking of adjacent pyrimidine bases in 
the same DNA chain (cyclobutane pyrimidine dimers (CPDs) or 6-4 
photoproducts). Defects in components of NER pathway are linked to the 
cancer syndrome xeroderma pigmentosum (XP). The failure to repair UV 
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photoproducts predisposes these patients to develop skin cancer associated 
with sunlight exposure (21). A second branch of the NER system senses 
lesions via stalled RNA polymerase II and is called transcription-coupled NER 
(22). The MMR system corrects errors during DNA replication that have been 
missed by the proofreading activity of the polymerases (23). In humans, 
generally, base-base mismatches and small insertion/deletion loops (IDL) are 
recognized by the heterodimer MutS (MSH2-MSH6), whereas larger IDLs 
are detected by MutS (MSH2-MSH3). The DNA bound MutS forms a ternary 
complex with MutL (MLh1-PMS2) and in an ATP-driven process the complex 
slides along DNA and searches for a nick in the DNA that serves as a signal 
to distinguish the newly synthesized erroneous DNA stand from the correct 
template strand. Loss of MMR becomes apparent in the instability of short 
repetitive DNA sequences (microsatellites) that are prone to be incorrectly 
synthesized by DNA poymerases and require post-replicative repair (24). 
 
 
Figure 1  
Target sites for intracellular DNA 
decay. A short segment of one 
strand of the DNA double helix is 
shown with the four bases (from top: 
guanine, cytosine, thymine, 
adenine). Sites susceptible for 
hydrolytic attack, oxidative damage, 
and non-enzymatic methylation by 
S-adenosylmethionine are indicated. 
The large arrows highlight major 
sites of damage. Adapted from (10). 
 
 
 
 
3.3. Homologous recombination 
Homologous recombination (HR) serves to eliminate DSBs from 
chromosomes by using an intact homologous DNA sequence as template for 
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repair. DSBs can be programmed, such as in meiosis to induce recombination 
between homologous chromosomes (25) or they can occur as unscheduled 
events during DNA replication or result from direct damage induced, for 
example, by ionizing radiation. Unprogrammed DSBs pose a serious threat for 
the cell. They must be repaired quickly and with sufficient accuracy to restore 
the integrity and functionality of the genome. As mentioned above, the cell 
has two distinct pathways to repair DSBs. In NHEJ the DNA ends are bound 
by the Ku70/80 heterodimer and a process is initiated that joins the DNA ends 
directly (26). This repair process can lead to sequence alterations at the 
breakpoint (27). In contrast, HR is an accurate repair mechanism, but requires 
the presence of a homologous DNA sequence elsewhere in the genome. HR 
functions therefore preferentially during the S and G2 phase of the cell cycle 
where the sister chromatid is available (28). How DSBs are directed for repair 
by the different pathways is not yet clear. In a recent study, it has been 
suggested that phosphorylation of CtIP as cell enters S phase could shift the 
balance of DSB repair from NHEJ to HR (29). CtIP promotes the resection of 
DNA ends and by this generates ssDNA tails, which could serve as substrate 
for HR (30). 
3.3.1 Mechanism of homologous recombination 
The classical DSB repair (DSBR) model was worked out in yeast studies on 
meiotic recombination and helps to explain several key features of mitotic HR 
to repair a spontaneous DSB (31). To initiate HR the end of a DSB is resected 
to generate a 3’-ssDNA tail that serves as substrate for the HR machinery 
(Fig. 2 A). The MRE11/RAD50/NBS1 (MRN) complex is a central player in the 
cellular response to DSBs. It binds to DSBs, promotes DNA end processing, 
and is involved in activation of the damage checkpoint kinase ATM (32). As 
mentioned above CtIP, is another protein required for DSB resection and 
interacts directly with the MRN complex (30). 
 Next, a catalytic nucleoprotein filament assembles on the ssDNA tail. 
The subunits of this filament belong to the RecA/Rad51 family of 
recombinases that promote strand invasion into a homologous DNA duplex 
and thus create a three-stranded DNA intermediate called displacement loop 
(D-loop) (Fig. 2 A). Presynaptic filament assembly as well as D-loop formation 
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is dependent on several recombination mediators and accessory factors (33). 
Firstly, for Rad51 to nucleate on ssDNA, the inhibitory effect of bound 
replication protein A (RPA) must be overcome. At least in yeast, Rad52 has a 
key role in the delivery of Rad51 to RPA-bound HR substrates (34,35), and S. 
cerevisiae rad52 mutants exhibit severe defects in DSB repair (36). Although 
vertebrates possess a Rad52 ortholog, other proteins seem to mediate Rad51 
filament assembly on ssDNA. In humans, five RAD51 paralogs (RAD51B, 
RAD51C, RAD51D, XRCC2, XRCC3) have been described that might 
participate in assembly and/or maintenance of RAD51 presynaptic filaments 
(37). In addition, two main mediators are BRCA1 and BRCA2. Both are 
required for normal levels of HR and cell lines defective in BRCA2 fail to 
accumulate RAD51 foci after DNA damage (38-41). Secondly, ATP-
dependent dsDNA translocases like RAD54 and RAD54B assist RAD51 in 
search for DNA homology and stimulate D-loop reaction (42). 
 In a next step of HR, the invaded DNA strand is extended from the 3’-
end by DNA synthesis (Fig. 2 A). A candidate for this DNA transaction is the 
translesion synthesis (TLS) polymerase  (Pol ). Human Pol  was identified 
to promote efficiently extension of an artificial D-loop substrate by a 
biochemical approach (43). 
 In the classical DSBR model, the displaced strand of the D-loop 
anneals to the ssDNA tail of the second DSB end (Fig. 2 B). Rad52 is 
suggested to promote this step. Rad52 exhibits ssDNA annealing activity 
even in presence of saturating amounts of RPA (44). Furthermore, yeast 
Rad52 in the presence of RPA was shown to capture ssDNA and facilitate the 
annealing with the displaced strand after Rad51-mediated strand exchange in 
vitro (45,46). The resulting DNA structure after second end capture, gap filling 
and ligation contains two Holliday junctions (HJs). This intermediate needs to 
be resolved to allow the repaired DNA molecules to separate (Fig. 2 B).  
 The resolution step of HR is much better understood in bacteria. The 
bacterial RuvABC enzyme complex acts on HJs and cleaves them 
symmetrically into linear duplex products (47). How the corresponding 
process takes place in eukaryotic cells is not well characterized. Mus81-Eme1 
was identified as a candidate protein complex with resolvase activity. 
However, at least in vitro, it shows higher activity on 3’-flaps, fork structures or 
 14
nicked HJs than on intact HJs (48-50). Recently, West’s laboratory reported a 
novel resolvase GEN1 (yeast otholog Yen1) that cleaves HJs, like RuvC, 
symmetrically to produce nicked duplexes that can be readily ligated (51). 
Depending on which pairs of DNA strands are nicked, HJ-cleavage products 
can give rise to crossover or non-crossover DNA molecules (Fig. 2 C). 
Crossovers that lead to exchange of chromosome arms are observed in 
meiosis and are essential for proper chromosome segregation (25). 
 Mitotic HR differs from meiotic HR. In mitotic cells, crossovers between 
homologous DNA molecules, that are usually sister chromatids, seems to be 
actively suppressed. The BLM helicase has an important role to suppress 
sister chromatid exchanges (SCEs). Acting together with topoisomerase III 
(TOPOIII), BLM is thought to migrate HJs between paired duplexes inward 
and the resulting hemicatenane structure is then resolved by TOPOIII to 
yield only non-crossover products (Fig. 2 D). This double HJ dissolution 
mechanism was demonstrated in vitro (52) and helps to explain the elevated 
level of SCEs observed in cells from Bloom’s syndrome patients (53). 
 Synthesis-dependent strand annealing (SDSA) is another proposed HR 
repair mechanism that is not associated with crossovers (54,55). By D-loop 
migration the invading strand is displaced after repair synthesis and re-
anneals with the second resected DSB end, which is not captured into the 
recombination intermediate (Fig. 2 E). Gap-repair DNA synthesis followed by 
ligation is then used to complete the repair process (Fig. 2 E). The yeast 
helicase Srs2 was recently suggested to promote SDSA, since it shows 
preference to unwind synthetic DNA structures that mimic a D-loop and is 
stimulated by Rad51 bound to double-stranded (ds) DNA (56).  
 DNA helicases are in general thought to control HR at different stages 
(57). They can negative regulate early steps of HR by direct disruption of 
Rad51 presynaptic filaments formed on ssDNA (see Chapter 3.5.3). 
Furthermore, the complex DNA structures that arise during HR such as D-
loops and HJs are preferred substrates for DNA helicases. Evidence that 
helicases have important roles in disruption/resolution of HR intermediates 
comes from studies in yeast. S.cerevisiae double mutants srs2 sgs1 that lack 
both Srs2 and the BLM ortholog Sgs1, show low viability. Interestingly, the low 
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viability of sgs1 srs2 mutants is suppressed by mutation in rad51 (58). These 
findings suggest that in the absence of Srs2 and Sgs1, Rad51-promoted DNA 
intermediates are not removed or maturated properly and become toxic for 
the cell. 
 
Figure 2 
Repair of DNA double-strand breaks. Double-strand breaks (DSBs) can be repaired by 
several homologous recombination (HR)-mediated pathways, including double-strand break 
repair (DSBR) and synthesis-dependent strand annealing (SDSA). (A) Repair is initiated by 
resection of a DSB to provide 3’-ssDNA overhangs. Strand invasion by a 3’-ssDNA overhang 
into a homologous sequence is followed by DNA synthesis at the invading end. (B) In the 
DSBR pathway the second DSB end is captured and after gap-repair DNA synthesis and 
ligation a DNA intermediate with two Holliday junctions (HJs) is formed. (C) This structure can 
by resolved at the HJs in a non-corossover (black arrow heads) or crossover mode (green 
arrow heads). (D) Alternatively, double HJs can be dissolved by migration of the HJs inwards 
and decatenation of the DNA molecules to give non-crossover products. (E) Another pathway 
to generate non-crossover products is SDSA. The reaction includes displacement of the 
invaded strand after DNA synthesis, re-annealing to the other resected DSB end, gap-filling 
DNA synthesis and ligation. Adapted from (57). 
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3.3.2 The RAD51 recombinase 
The catalytic core of the HR machinery consists of proteins belonging to the 
RecA/Rad51 family of recombinases that assemble into nucleoprotein 
filaments on ssDNA and promote homologous DNA pairing and strand 
exchange. In eukaryotes, two orthologs of the E.coli recombinase RecA exist, 
RAD51 and DMC1. RAD51 is needed for mitotic and meiotic HR, whereas 
DMC1 function is restricted to meiotic HR as it is only expressed in meiosis. 
S.cerevisiae rad51 mutants are viable. However, RAD51 is essential in higher 
eukaryotes. Deletion of Rad51 from the genome in mice is lethal (59,60) and 
vertebrate cells rapidly accumulate chromosome aberrations and stop dividing 
when RAD51 expression is suppressed (61).  
 The human RAD51 recombinase is a relatively small protein of about 
37 kDa and the core domain, homologous to RecA, contains the Walker A 
and B motifs responsible for ATP binding and hydrolysis (Fig. 3 A). As other 
recombinases, RAD51 exists as homo-oligomer in solution and forms 
heptameric ring structure (62) (Fig. 3 B). RAD51 binds both ss and dsDNA 
showing preference for dsDNA with a ssDNA tail (63,64). The catalytically 
active form of RAD51 is a highly ordered right-handed helical nucleoprotein 
filament on ssDNA (65) (Fig. 3 B). In this complex, the DNA is held in an 
extended conformation, being stretched by as much as 50% of the length of a 
canonical B-form DNA helix (66,67).  
 The reaction catalyzed by the competent RAD51 filament, which is 
search for homologous sequence in duplex DNA and strand exchange, is not 
completely understood. It is thought that rapid exchange of A:T base pairs is 
essential for homology recognition and formation of initial paranemic joints 
(68). Interestingly, RAD51 filament was reported to localize homologous 
sequence even on the surface of nucleosomal DNA and promote formation of 
paranemic joints that can be converted into stable plectonemic joints by 
RAD54 (69). 
One important prerequisite for catalytically competent RAD51 filament 
is bound ATP. Under in vitro conditions, inhibition of the ATPase activity of 
RAD51 leads to stabilized presynaptic filaments and an enhanced ability of 
RAD51 filaments to catalyze the strand-exchange reaction. As a 
consequence, the use of a nonhydrolyzable nucleotide analogue (such as 
 17
 
Figure 3 
Structures of RecA/Rad51 family recombinases. (A) Schematic representation of E. coli 
RecA, human RAD51 and human DMC1, showing their characteristic motifs (adapted from 
(70). (B) RAD51 forms heptameric ring structures in solution, as indicated schematically and 
in the electron microscope (EM) image of archaeal RAD51 (adapted from (62)). The 
catalytically active RAD51 is associated with ssDNA in the form of a highly ordered right-
handed helical nucleoprotein filament, indicated schematically. The nucleoprotein filament 
has a pitch of 95-100Å, comprising 6 RAD51 proteins and 18 nucleotides of the DNA ligand 
per helical repeat (67). The EM image shows a nucleoprotein filament assembled from 
human RAD51 (adapted from (71)). Filaments formed on ssDNA by human RAD51 (a), S. 
cerevisiae Rad51 (b), and E. coli RecA (c) are illustrated by three-dimensional surfaces 
reconstructions (adapted from (67)). 
 
 
AMP-PNP) (63,69,72), calcium ions in the reaction (72,73) or RAD51 mutants 
that bind but cannot hydrolyze ATP (63), highly stimulates RAD51 function. 
Moreover, over expression of such ATPase-defective RAD51 mutants, yeast 
Rad51K191R or human RAD51K133R, is needed to compensate for the loss 
of endogenous RAD51 in vivo (74,75). These findings raise at least two 
questions. Firstly, what is the role of ATP hydrolysis for the RAD51-promoted 
reaction, and secondly, how can a stable filament form in vivo. It is 
demonstrated that ATP hydrolysis is linked to dynamic disassembly of the 
filament (72). The fast turnover of the RAD51 filament is thought to generate 
an intracellular pool of free RAD51 proteins available for HR and DNA repair 
reactions (63). A crucial role in the stabilization of RAD51 filaments in vivo 
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might have the several known HR mediators and accessory factors (33). 
Especially, BRCA2 is reported as universal RAD51 regulator. BRCA2 
interacts directly with RAD51 via BRC repeats and a C-terminal region. 
BRCA2 is reported to target RAD51 to ssDNA, influences its oligomerization 
state and the stability of the formed RAD51 filament on DNA (70,76).  
 
3.4 DNA Replication 
DNA replication is the process by which the cell copies its genome. To 
maintain genetic information each DNA strand must be accurately and 
completely duplicated exactly once before each cell division. In the first part of 
the chapter (3.4.1) the global process during undisturbed DNA replication is 
explained. In the second part of the chapter (3.4.2) it is described how the 
replication machinery copes with damaged DNA or other situations that block 
the replication process.  
 
3.4.1 Global DNA replication process 
Duplication of the genome starts at replication origins. At these sites, the DNA 
double helix is melted and two replication forks are initiated. The replication 
forks then move along the DNA, replicating each strand as they progress. At 
the fork, several factors are organized in a complex called a replisome that 
allows coordinated copying of the antiparallel template strands by DNA 
polymerases (Pols). These enzymes synthesize DNA in 5’3’ direction. 
Therefore, the two polymerase molecules copying the template strands move 
in opposite directions, one producing a continuous leading strand, while the 
other generates a lagging strand in a discontinuous fashion by synthesis of 
short so-called Okazaki fragments (Fig. 4). In E. coli, both nascent strands are 
synthesized by Pol III. Efficient replication of the eukaryotic genome requires 
three major DNA polymerases: Pol , Pol , and Pol  (77). Pol -primase 
complex initiates DNA synthesis by generating a short RNA primer that is 
elongated by its DNA polymerase activity to form a short stretch of DNA, 
allowing Pol  and Pol  to perform the bulk of chain elongation. Pol  and Pol 
 are both highly selective for correct nucleotide insertion and have intrinsic 
proofreading exonuclease activities. Hence, the error rate of these 
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polymerases is in the 10-6 to 10-8 range (11). Recent studies in yeast specify 
Pol  as the leading-strand and Pol  as the lagging-strand polymerase during 
undisturbed DNA replication (78,79) (Fig. 4). This division of labor model at 
the eukaryotic replication fork is based on analysis of error patterns caused by 
mutator variants of Pol  or Pol  in a target sequence inserted next to a well-
defined replication origin (78,79). Evidence implicating Pol  in lagging-strand 
replication is in addition provided by its role in Okazaki fragment maturation 
(80). Every 100-200nt on the lagging strand, Pol  runs into the RNA primer of 
the previous Okazaki fragment and is able to perform strand-displacement 
DNA synthesis, thus generating a 5’-flap structure that can be cleaved by flap 
endonuclease 1 (Fen1) or Dna2 and ligated by DNA ligase I (80,81). 
Furthermore, Pol  seems to correct errors made by Pol  that has a lower 
fidelity because of lack of intrinsic proofreading activity (82).  
 A key factor that coordinates proteins at the replication fork is the 
proliferating cell nuclear antigen (PCNA). PCNA is proposed to encircle 
dsDNA as a trimer (83), forming a siding clamp that enhances the processivity 
of polymerases and recruits proteins to DNA (84). Other important factors 
participating in DNA replication are the ssDNA binding protein RPA, DNA 
helicases and topoisomerases. DNA strand separation by helicases at the 
replication fork generates ssDNA that is bound and protected by RPA. DNA 
unwinding leads to accumulation of positive supercoiling ahead of the fork that 
opposes further fork progression and requires the action of topoisomerases 
(85). 
 Apart from the higher complexity observed in eukaryotes, the 
mechanism of DNA replication seems fairly conserved from bacteria to higher 
eukaryotes. However, an important difference concerns the shape of the 
genome. Most bacteria have a single circular chromosome. E. coli, for 
example, replicates its 4.7 106bp genome from a single sequence-defined 
origin. Not only the initiation of bacterial DNA replication, but also its 
termination is a controlled process. Termination (Ter) sequences and bound 
Tus proteins allow progression of the replication fork only in one direction and 
constrain the replication forks to converge at a terminus region located 
opposite to the origin (86). The situation in eukaryotes is much more complex. 
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Replication of several linear chromosomes in the cell needs to be 
synchronized. On each chromosome, a large number of origins are used, 
typically spaced 30-100kb apart (87). Origins are established at origin 
recognition complex (ORC) bound DNA sites, which are often not defined by 
sequence in metazoa (88). During late mitosis and G1, pre-replication 
complexes (pre-RCs) are assembled by loading the minichromosome 
maintenance (MCM) 2-7 proteins (87). MCM2-7 proteins are essential for 
initiating and elongating replication forks during S phase. Hence, these 
proteins are suggested to function as a replicative helicase. Eukaryotic cells 
seem to control the replication from their multiple origins in a flexible way. 
More pre-RCs are assembled than are activated during S-phase, thus firing of 
individual origins is inefficient and it is proposed that pre-RCs at silent origins 
are destroyed by passage of replication forks from active origins (88).  
 
Figure 4 
The eukaryotic replication fork 
model. During undisturbed DNA 
replication, synthesis of the leading 
and lagging strand is performed by 
Pol  and Pol , respectively. A 
minimal replisome is shown 
consisting of the MCM helicase, 
RPA, PCNA, Pol -primase 
complex that synthesizes 
RNA/DNA primers, Pol  and Pol  
responsible for the bulk of DNA 
replication, and the Okazaki 
fragment maturation proteins 
FEN1/DNA Ligase. By loop 
formation of the lagging-strand 
template, Pol  is thought to move 
coupled with Pol  in direction of the 
progressing fork. Arrows represent 
the 3’-end of DNA strands. Adapted 
from (79). 
 
 
3.4.2 Processing of stalled replication forks 
DNA replication is exposed to a variety of situations that may challenge the 
progression of replication forks, thus endanger genome integrity. In E. coli, it 
is assumed that about 18% of cells require replisome reloading outside the 
origin during a single round of chromosome duplication in the absence of 
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exogenous DNA damaging agents (89). In both, prokaryotes and eukaryotes, 
replication-fork blockage, eventually collapse of the fork because of replisome 
disassembly is though to arise often from different sources. A damaged DNA 
base can stall the replicative polymerase on one arm of the fork; a roadblock 
in the template duplex ahead of the fork, such as tightly bound proteins or a 
inter-strand DNA crosslink, can stall the whole replisome; a nick in the 
template strand can result in a one-ended DSB. Therefore, recovery from the 
different types of replication-fork damage requires multiple fork-reactivation 
pathways. 
  
3.4.2.1 Pathways in bacteria 
In E. coli, replication arrest by defects in replicative enzymes or as a result of 
DNA damage has been the subject of extensive studies in the past years. To 
replicate the circular chromosome from a single origin, the bacterial replication 
machinery relies on a close interplay with recombination and DNA repair 
proteins (90,91). Two studies on E.coli replication mutants led to the proposal 
of a replication-reactivation model in which a HJ forms at blocked replication 
forks. In the first study, replication-associated DSBs were demonstrated in 
helicase-defective mutants (dnaB and rep) in the absence of functional HR 
due to a lack of RecBCD (92). The E. coli RecBCD, a helicase-exonuclease 
complex, is a key factor in HR that degrades DNA from a DSB end and 
generates the 3’-ssDNA overhang substrate for RecA upon encountering a 
regulatory sequence called Chi (93). In the second study, the fragmentation of 
chromosomal DNA in cells lacking Rep helicase and the RecBCD complex 
could be suppressed by inactivation of the RuvABC proteins (94). Therefore, it 
is thought that replication arrest leads to a reaction called replication-fork 
regression. This reaction involves the unwinding of the two arms of the fork, 
annealing of the nascent strands and repairing of the parental strands to form 
a four-way DNA structure, similar to a HJ (Fig. 5 B). In RecBCD-proficient 
cells the regressed arm can be processed from the end without breakage 
(Fig. 5 F). In the absence of RecBCD, the RuvABC complex alternatively 
processes the four-way DNA and generates a one-ended DSB that depends 
on functional HR to be repaired (Fig. 5 D). The genetic data support this 
model. The viability of rep recBC mutants could be restored by inactivation of 
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the ruvAB operon (94). Hence, no irreparable DSBs are formed at arrested 
forks and replication is channeled in an alternative restart pathway. This 
concept of chromosome fragmentation after HJ formation at the arrested 
replication fork was confirmed with other replication mutants (dnaE, dnaN, 
and holD) and a priA mutant, defective in the main replication-restart pathway 
(95-97).  
 Originally, it was thought that conversion of an arrested fork into a HJ 
facilitates replisome reloading in a HR-dependent way and promotes restart of 
collapsed replication forks (90,94). Biochemical studies showed later that the 
replicative helicase DnaB can be loaded directly on a fork structure and DNA 
synthesis can be re-initiated even on the leading strand outside the origin 
(98,99). Two different direct enzymatic restart systems are reported. The first 
system depends on PriA that can restart a collapsed replication fork when the 
3’-end of the nascent leading strand is near the fork junction and in addition 
can promote restart from a D-loop substrate (98-100). The second system, 
which is PriC-dependent, initiates replication on a fork with a leading-strand 
gap (98,99).  
 Fork structures with a long leading-strand gap were observed in vivo. A 
lesion in the leading-strand template can uncouple nascent strand 
polymerization at the fork; while the leading-strand polymerase is blocked, 
unwinding of the replication fork and lagging-strand synthesis can continue for 
some distance (101). Replication through base lesions requires specialized 
DNA polymerases called translesion synthesis (TLS) polymerases (Fig. 5 A) 
(100). TLS polymerases are able to insert bases opposite DNA lesions that 
block the major replicative polymerases at the expense of low-fidelity (11). 
Alternatively, in the direct PriC-dependent restart pathway, the gaps with a 
lesion left behind are proposed to be repaired in error-free manner by HR 
using undamaged sister chromatid (Fig. 5 C). Mutants in priA, in which only 
the PriC restart system is functional, require the RecFOR gap-filling 
recombination proteins for viability (102). Furthermore, Courcelle’s laboratory 
reported that UV lesions that block replication are processed and repaired 
through a transient X-shaped DNA structure in E.coli (103). They propose that 
fork regression sets back the replication-blocking lesion to the parental duplex 
allowing repair enzymes to gain access. In a recent study, they provided 
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evidence for the involvement of the RecJ-RecQ nuclease-helicase complex in 
rapid recovery of DNA synthesis after UV damage (104). RecJ-RecQ 
preferentially degrades the nascent lagging strand at blocked forks (105). 
Therefore, processing of a stalled fork with a leading-strand gap by RecJ-
RecQ is thought to allow re-annealing of the parental strands and removal of 
the lesion by the excision repair machinery from the parental duplex (104). In 
the absence of RecJ, or to a lesser extent RecQ, both recovery of replication 
and cell survival become dependent on the TLS Pol V (104). 
 In most conditions of replication inactivation, the mechanism by which 
a blocked replication fork is converted into a HJ remains unknown. 
Replication-fork regression can in principle be spontaneous or enzyme-driven. 
Positive superhelical stress built up in front of the replication fork can be 
relived by fork regression. It has been demonstrated that introduction of 
positive supercoiling into partially replicated plasmids causes fork regression 
in vitro (106,107). Alternatively, helicases or recombinases could actively 
drive the regression process at blocked forks. The bacterial helicase RecG 
binds and unwinds forked DNA structures and can promote HJ branch 
migration (108). Furthermore, it can convert fork structures into HJ (109,110) 
and shows an efficient fork-regression activity on a M13-based fork structure 
with a long leading-strand gap (111). The crystal structure of RecG bound to a 
synthetic forked DNA suggests that monomeric RecG can promote fork 
regression by simultaneously unwinding of the two nascent arms and 
annealing of the parental strands (112). RecG is though to translocate along 
the parental duplex in opposite direction to replication. A motif called a wedge 
domain is involved in stripping off the nascent strands at the fork junction and 
frees them for annealing, while the complementary parental strands are 
directed to narrow channels on each side of the wedge domain that can only 
accommodate ssDNA. In vivo data further suggested a role for the UvrD 
helicase in fork regression (113,114), and also implicated the branch 
migration complex RuvAB in converting a stalled fork into a HJ (115). By an 
alternative mechanism, fork regression can also be promoted by the RecA 
recombinase. On fork structures with a ssDNA gap, RecA can form a 
nucleoprotein filament and catalyze strand exchange with the homologous 
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sister arm. In vitro, RecA was found to regress a M13-based fork structure 
with a 2.1kb leading-strand gap (116).  
 
 
Figure 5 
Potential pathways resulting in reactivation of replication forks stalled by a leading-
strand specific lesion. When the replisome encounters a lesion (black triangle) in the 
leading-strand template leading- and lagging-strand synthesis can become uncoupled 
resulting in a stalled fork with a leading-strand gap. (A) Specialized DNA polymerases called 
translesion synthesis polymerases are able to replicate past lesions in an error-prone 
pathway. (B) Fork regression is thought to convert a stalled replication fork into a four-way 
DNA structure similar to a Holliday junction (HJ) that serves as intermediate for several 
reactivation mechanisms (D-F). (C) Alternatively, DNA synthesis may directly reinitiate and 
the gap with the lesion could be repaired later in a recombination-mediated error-free 
pathway using complementary DNA from the sister duplex. (D) After HJ cleavage the broken 
DNA end can undergo a strand invasion into the intact homologous duplex and DNA 
synthesis can be restarted from a D-loop. (E) By template switching, the complementary 
nascent strand is used for DNA synthesis, following reversal of the regressed fork. Thereby 
the lesion is bypassed in a error-free manner without removal. (F) Furthermore, fork 
regression sets back the blocking lesion to the parental duplex where it can be removed by 
excision repair. The fork structure could be restored by an exonuclease (indicated in orange) 
that degrades DNA of the regressed arm. The arrow heads represent the 3’-end of DNA 
strands and the dotted lines DNA extension past the lesion. This figure is adapted from (117). 
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3.4.2.2 Pathways in eukaryotes 
Processing of damaged replication forks might be of similar importance in 
eukaryotic cells, so there could be analogous systems for reactivation of 
arrested forks to those in prokaryotes. However, eukaryotes could also use 
the presence of multiple origins on each chromosome. Hence, a fork from an 
adjacent origin might converge on a damaged fork to complete replication 
from the opposite site. Two major pathways are thought to operate on blocked 
replication forks in eukaryotes: an error-prone pathway that relies on TLS 
polymerases that can progress though certain types of lesions that block 
replicative polymerases and an error-free repair pathway largely dependent 
on HR.  
Replication of SV40 derived plasmids with a CPD in the leading-strand 
template in human cell extracts showed a temporary arrest at the lesion, 
leading to uncoupling of the leading- and lagging-strand synthesis and finally 
lesion bypass without repair in about 50% of the daughter plasmids (118,119). 
Replication–competent extracts from XP-variant cell line were found severely 
impaired in CPD bypass (118,119). XP-variant cells are defective in the TLS 
Pol  that is able to replicate past CPDs (120). The switch to a TLS 
polymerase is proposed to involve post-translational modifications including 
monoubiquitination of the sliding clamp PCNA at stalled replication forks 
(121).  
 Also in eukaryotes, recombination is believed to assist replication. 
RAD51 function is indispensable in the maintenance of chromosomal DNA 
during normal cell cycling (61). Substrate for HR repair machinery is likely 
generated by collapse of replication fork at endogenous single strand breaks 
(SSBs). Challenging replicating cells with SSBs following camptothecin 
treatment or using cells deficient in SSB repair (XRCC1-deficient) triggers 
RAD51-dependent HR events (122), suggesting a role for HR in reactivation 
of broken replication forks. Programmed replication-fork barriers (RFBs) in 
certain regions of the chromosomes that slow down fork progression have 
often been invoked to explain the nature of specific hot spots for 
recombination (123). In a study in yeast, the consequence of fork arrest by 
introducing a RFB at an ectopic site was analyzed (124). The used RFB 
consists of a non-histone protein/DNA complex. Proteins implicated in HR 
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were found to be recruited to the ectopically blocked replication site and 
promote recombination events that allow cells to survive, but are sometimes 
associated with gross chromosomal rearrangements (124). 
 How transiently blocked replication forks are processed is not yet 
completely understood. A reactivation pathway through a transient HJ was 
originally also suggested for eukaryotes. Moreover, fork regression was 
postulated to allow bypass of a lesion by using the complementary nascent 
strand as template for error-free DNA synthesis (125) (Fig. 5 E). This 
mechanism called template switching, although conceptually attractive, is 
controversial. Direct visualization of replication intermediates by electron 
microscopy (EM) in yeast showed regressed replication forks only in 
checkpoint-defective mutants (rad53) after hydroxyurea (HU) treatment (126). 
HU is an inhibitor of ribonucleotide reductase that slows down replication by 
limiting dNTP pools. Rad53 is an effector kinase that is activated after DNA 
damage (127). The authors proposed therefore that Rad53 activity maintains 
the stability of stalled replication forks and prevents accumulation of 
pathological DNA rearrangements including regressed forks (126).  
 Nevertheless, enzymatic activities that could promote fork regression 
are reported for eukaryotes as well. Recently, a FA protein, FANCM, which 
functions as DNA translocase, has been shown to promote extensive fork 
regression of a plasmid-based fork structure with a short lagging-strand gap 
(128). In another study, the BLM DNA helicase has been shown to catalyze 
the regression of a plasmid-based model fork with a short leading-strand gap 
in vitro (129). Moreover, another human RecQ helicase, WRN, is capable to 
regress synthetic fork structures (130). In addition, human RECQ5 protein has 
been shown to promote efficiently strand-exchange reactions between 
homologous arms of oligonucleotide-based fork structures (131). Whether 
RECQ5 is able to carry out a regression reaction of a large M13-based model 
fork is analyzed in the first part of this thesis.  
 In yeast, there is evidence for a transient template-switching 
mechanism for error-free damage bypass following PCNA polyubiquitination 
(132,133). Rad5, a protein with DNA-dependent ATPase activity and a RING 
finger motif characteristic of ubiquitin ligase proteins (134), presumably 
mediates PCNA polyubiquitination. In biochemical experiments, Rad5 was 
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shown to be able to regress plasmid-based fork structures (135). Hence, 
Rad5 could directly act at stalled replication forks and promote template 
switching by fork regression. Two human orthologs of the yeast Rad5, 
SHPRH and HLTF, both involved in PCNA polyubiquitination have been 
described, suggesting the existence of this DNA damage bypass mechanism 
in human cells (136,137).  
 Finally, EM analysis of replication intermediates in yeast mutants 
challenged with irreparable UV lesions suggests repriming of DNA synthesis 
downstream of the lesions on both leading and lagging strands (138). After 
UV treatment of excision-repair defective mutants (rad14) uncoupling of 
leading- and lagging-strand synthesis was observed. Long ss gaps up to 3kb 
length at forks are seen. Furthermore, internal ssDNA gaps accumulate along 
replicated duplexes on both arms of the fork. Interestingly, defects in TLS 
(rev1 and rev3) and HR (rad52) did not affect fork progression over damaged 
template, but increased internal gap accumulation, suggesting repriming of 
DNA synthesis, post-replicative recombination-mediated repair and TLS that 
might take place behind the replication fork (138). 
 In conclusion, multiple reactivation pathways seem to operate also in 
eukaryotes. How stalled forks are directed to distinct repair/bypass pathways 
is unclear. However, failure to process stalled forks, which might lead to 
breakage, is an important source of genomic instability. 
 
3.5 Helicases 
3.5.1 Overview 
Helicases are nucleic acid-dependent ATPases that are capable of unwinding 
DNA or RNA duplexes (139-141). As a consequence, they are involved in 
almost all biological processes where complementary nucleic acid strands 
have to be separated. More recently, it has become clear that several putative 
helicases do not unwind duplex DNA or RNA. Helicases therefore represent 
only a subgroup of motor proteins that all translocate directionally along ss or 
ds nucleic acids but do not necessarily have unwinding activity (142). Other 
transactions performed by these enzymes are displacement of proteins bound 
to DNA (chapter 3.5.3) or RNA and chromatin remodeling (143). 
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Helicases/translocases have been classified into six superfamilies 
(SFs) based on short conserved amino acid motifs (142). These helicase 
motifs include key residues of the functional translocase domain. SF1 and 
SF2 are related, are the largest SFs and contain at least seven conserved 
helicase motifs (1, 1a, 2-6) (144) (Fig. 6). Additional motifs have later been 
included for SF1 and SF2 helicases: TxGx (145), Q-motif (146), motif 4a 
(147), and TRG (148). SF1 and SF2 members function mainly as monomers 
or dimers (142). Well-characterized representatives of SF1 are the bacterial 
helicases Rep, PcrA, UvrD and the S. cerevisiae Srs2. Intensively studied 
members belonging to SF2 are, for example, the bacterial RecG and the 
RecQ family helicases. SF3-6 consist of helicases that form hexameric ring 
structures and share three to five superfamily-specific motifs (142). SF3 
includes putative helicases found in the genome of small DNA and RNA 
viruses. SF4 consists of proteins that are related in sequence to the E. coli 
replicative helicase DnaB and SF5 is exemplified by the bacterial transciption 
termination factor Rho. Finally, SF6 consists of a subgroup of proteins 
belonging to the AAA+ (ATPases Associated with various cellular Activites) 
family and includes the MCM proteins and RuvB.  
 
Figure 6 
Schematic diagram representing organization and involvement in the catalytic 
functions of conserved motifs of DEAD-box helicases (Superfamily 2). Open boxes 
represent the conserved helicase motifs. The consensus amino-acid (aa) sequence of each 
motif is shown by the single-letter code inside the boxes (z = D, E, H, K, R; o = S, T; x = any 
aa). Motifs are labeled above the boxes according to new nomenclature (142). Numbers 
above the arrows are typical ranges of aa residues found between the motifs. Adapted form 
(141). 
 
 
 
 
 29
3.5.2 Mechanism of DNA unwinding 
DNA helicases convert the chemical energy from ATP hydrolysis into 
mechanical energy to translocate along ssDNA with either 3’5’ or 5’3’ 
polarity and unwind duplex DNA in the process. A monomeric enzyme is 
thought to contain at least two DNA-binding sites: the leading (L) site binds to 
ssDNA or ss/dsDNA and the trailing (T) site binds only ssDNA. Coupled to 
ATP binding and hydrolysis, the enzyme changes its conformation from a 
compact form to an extended form. In the process, the L and T sites 
sequentially alter DNA-binding affinity from weak to tight which results in a 
directional inchworm-like movement (149) (Fig. 7). The DNA strand 
separation can then proceed via an active or a passive mechanism. In the 
passive mechanism, the helicase does not make contacts with the duplex. 
Instead, it operates by trapping ssDNA at a thermally fraying ss-dsDNA 
junction. In the active mechanism, the helicase interacts directly with dsDNA 
and destabilizes the duplex. For PcrA, such a dsDNA contact is described. 
Residues located outside of the helicase core mediate this contact. This 
causes double helix distortion and is therefore proposed to facilitate strand 
separation (150). 
From crystal structures of diverse enzymes, it turns out that the 
minimal structural unit of a translocase, also called core domain, folds into 
neighboring RecA-like domains either within the same polypeptide chain or 
between subunits (140,142). In the cleft between two RecA-like domains the 
ATP binding and hydrolysis takes place. The conserved helicase motifs are 
located on the surface of the cleft. For SF1 and SF2 enzymes, motifs 1 and 2 
are equivalent to the Walker A and B motifs found in ATPases, respectively 
(151) (Fig. 6). Motif 1 has a consensus sequence GK(T/S). The lysine residue 
in motif 1 interacts with the phosphates of ATP/ADP and the hydroxyl of the 
threonine or serine residue ligates the Mg2+ ion. Motif 2 takes the general form 
of DExx across SF1 and SF2. Subgroups of SF2 are classified according to 
the DExx motif into DEAD-, DExD- or DExH-box families (141). The carboxyl 
of the aspartate residue in Motif 2 coordinates the Mg2+ ion of 
MgATP/MgADP, whereas the glutamic acid residue is suggested to act as a 
catalytic base in ATP hydrolysis. Another universal feature of the RecA-like 
ATPase core is an “arginine (R) finger” that plays a key role in energy 
 30
coupling (142). Both, SF1 and SF2 members have an R in the middle of motif 
6. In the structure of PcrA complexed with an ATP analog, the guanidinium 
group of the corresponding R forms a salt bridge with the  phosphate of ATP 
(151). Other contacts with ATP are mediated by motif Q containing an 
invariant glutamine within an amino acid stretch upstream of motif I. Motifs 1a, 
TxGx and 4 are suggested to be involved in ssDNA binding (140). 
 
 
Figure 7 
Cartoon of inchworm-like movement of helicases/translocases along DNA. A 
monomeric enzyme is represented with two DNA-binding sites, a leading (L) site and a trailing 
(T) site. The enzyme changes its conformation coupled to ATP binding and hydrolysis from 
compact to extended. In the process altering weak and tight DNA binding of the L and T site 
results in unidirectional translocation along DNA. 
 
 
Crystal structures of helicases in complex with DNA substrate and ATP 
hydrolysis intermediates provide insight into the molecular mechanism of DNA 
unwinding. Such structures are, for example, available for PcrA and UvrD 
(152,153). Both enzymes are organized into four domains. Domains 1A and 
2A form the RecA-like ATPase core. Crystal structures of UvrD showed that 
one UvrD molecule is associated with the ss-ds junction of the DNA substrate, 
which is held in a L-shaped conformation (153) (Fig. 8). The 3’-ssDNA tail 
binds across the surface of the two RecA-like domains 1A and 2A. Domains 
1B and 2B contact the duplex DNA without disturbing the regular B form helix. 
Upon ATP binding (AMPPNP) the cleft between 1A and 2A is closed (Fig. 8). 
In addition, domains 2A and 1A/1B/2B with bound DNA duplex are rotated 
towards each other by 20°. This conformational change of the protein is 
suggested to be the first part of the ATPase-driven power stroke that leads to 
separation of the first base pair at the ss-ds DNA junction. Note that the now 
unpaired base (-1) of the ssDNA tail bound by UvrD is bulged out (Fig. 8 B). 
The second part of the power stroke, which is coupled to the release of ADP 
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and Pi after ATP hydrolysis, mediates domain opening and allows 
translocation of the ssDNA across domains 1A and 2A. This study led to the 
proposal of a combined wrench-and-inchworm mechanism for DNA unwinding 
by UvrD at the step size of 1bp per ATP hydrolyzed (153). 
 
 
Figure 8 
Crystal structures of UvrD complexed with partially ss-ds synthetic DNA. UvrD contains 
domains 1A (green), 1B (beige), 2A (blue), 2B (cyan). 1A and 2A form the RecA-like ATPase 
core. UvrD is shown in molecular surface with the front of molecule removed to expose the 
bound DNA (yellow) (A) Binary complex of UvrD and DNA. (B) Ternary complex of UvrD-DNA 
and the ATP analog AMPPNP. Functionally important regions are highlighted. Anchor 
(orange) is referred to residues in helicase motif 3 that function as an “anchor” for ssDNA 
during transition from binary to ternary complex. GIG-motif (orange), gating helix (pink), and 
separation pin (pink), are sequence motifs conserved among UvrD homologs including yeast 
Srs2. Adapted from (153). 
 
 
3.5.3 Function in protein-DNA complex disruption 
Translocases that move along DNA or RNA are likely to encounter proteins 
that are bound to nucleic acid. Moreover, some enzymes containing helicase 
motifs function directly in removing proteins from nucleic acid during various 
biological processes. For example, progression of replication through 
chromosomal sites bound by non-histone protein complexes is facilitated by 
accessory helicases to the replication machinery. These helicases belong to 
the Pif1-like subfamily and are highly conserved among eukaryotes (154). The 
best-characterized representative is the S. cerevisiae Rrm3. Rrm3 is a 5’3’ 
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DNA helicase of the SF1 (155). RRM3 is not an essential gene, but in its 
absence, replication forks pause at over 1000 discrete sites, including rDNA 
genes, tRNA genes, centromers, inactive replication origins, telomers and 
subtelomeric regions (155-157). At rDNA pausing sites, it has been shown 
that in the absence of functional Rrm3 both fork breakage and recombination 
are increased suggesting that blocked replication forks collapse (156,158). 
The second Pif1-like helicase of S. cerevisiae, Pif1, has been shown to 
function at telomeres. Pif1 is a negative regulator of telomerase, the reverse 
transcriptase that maintains telomeric DNA (159) and was shown to displace 
active telomerase from DNA ends (160). 
Another biological process where protein-DNA complex disruption has 
a relevant role is HR. Some helicases act as anti-recombinases by disrupting 
recombinase-nucleoprotein filaments and are thought to prevent thereby 
inappropriate HR events. Helicases with anti-recombinase function are found 
from bacteria to man. The E. coli UvrD helicase dismantles RecA 
nucleoprotein filaments and inhibits RecA-mediated strand-exchange reaction 
in vitro (161). In addition, genetic evidence suggests that UvrD acts at blocked 
replication forks and removes either RecA directely from ssDNA or RecA-
promoted structures (114). The E. coli replication mutants (dnaE, dnaN) 
require UvrD for viability. The lethality of those double mutants (dnaE or dnaN 
and uvrD) can be suppressed by inactivation of recombination proteins (recA, 
recJ, recFOR, or recQ) (114). 
The S. cerevisiae Srs2 protein is a 3’5’ DNA helicase (162) 
structurally and functionally related to UvrD (153,161). Accordingly, srs2 
mutants show a hyper-recombination phenotype (163) that can be 
suppressed by mutations that prevent formation of the Rad51 nucleoprotein 
filament (58,164). By biochemical studies, Srs2 was demonstrated to act as 
translocase that disassembles Rad51 nucleoprotein filaments (165,166). 
Regulation of HR at an early step by antagonizing RAD51 filament 
formation is expected to take place in higher eukaryotes as well. However, 
sequence homologs of SRS2 are not clearly apparent in the genome of higher 
eukaryotes. It is therefore expected that alternative helicases carry out 
presynaptic filament disruption in a way like Srs2. In humans, the F-box DNA 
helicase 1 (hFBH1) was identified to possess sequence similarities to the 
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helicase domains of Srs2 and UvrD (167). Furthermore, hFBH1 is able to 
rescue some recombination defects in yeast srs2 mutants (167). In a screen 
for functional equivalent of the yeast Srs2 in C. elegans, the helicase RTEL-1 
was found (168). Purified human RTEL1 was shown to disrupt D-loops, but 
not RAD51 filaments (168). In contrast, two RecQ family helicases, BLM and 
RECQ5, were recently demonstrated to be able to displace RAD51 from 
ssDNA, in the same manner like Srs2 (169,170). The second part of my thesis 
addresses the mechanism underlying the RECQ5-mediated displacement of 
RAD51 from ssDNA.  
 
3.5.4 RecQ family of DNA helicases 
RecQ DNA helicases belong to SF2. The first RecQ family member was 
discovered in E. coli in a screen for mutations that confer resistance to 
thymine starvation (171). Most unicellular organisms express only one RecQ 
family member, whereas higher eukaryotes typically express multiple RecQ 
proteins. Humans possess five family members, namely RECQ1, BLM, WRN, 
RECQ4 and RECQ5 (Fig. 9). A feature that makes RecQ proteins of particular 
interest is their implication in human diseases. Germ line mutations in three of 
the five human RecQ family genes (BLM, WRN, RECQ4) give rise to genetic 
disorders associated with cancer predisposition, premature aging and/or 
developmental abnormalities (172,173). RecQ helicases play a crucial role in 
maintenance of genome stability through their involvement in DNA 
recombination, replication, and repair (174-177). 
RecQ family proteins share a region of primary sequence similarity of 
approximately 400 aa in which the seven classical helicase motifs (144) and a 
Q-motif (called O-motif) are located (178). The crystal structure of the catalytic 
core fragment of E. coli RecQ (RecQC) shows that the helicase domain 
consists of two typical RecA-like modules (179) (Fig. 9 domains colored 
magenta and blue). Unique to RecQ helicases is the so-called RecQ C-
terminal (RecQ-Ct) domain that follows the helicase domain in the majority of 
RecQ family members (180). The RecQ-Ct domain consists of two 
subdomains: a zinc-binding motif (Fig. 9 yellow) and a helix-turn-helix motif, 
called winged-helix (WH) domain (Fig. 9 green) (179). The zinc-binding motif 
has been shown to be important for protein stability and the helicase activity 
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of the enzyme (181-183). The WH domain is predicted to be important for 
dsDNA binding (179). However, WH domain is dispensable for unwinding 
activity, as exemplified by RECQ5 (here RECQ5), which lacks this domain 
and is active as DNA helicase (184). Some RecQ family members contain 
another structural domain capable of DNA binding, the helicase and RNaseD 
C-terminal (HRDC) domain (Fig. 9 beige) (180,185,186). Variations in DNA-
binding residues of the HRDC domain are thought to confer DNA substrate 
specificity among RecQ proteins (185,187). Eukaryotic RecQ family members 
possess additional domains flanking the RecQ homology regions that show 
little or no sequence homology (Fig. 9 grey). These domains have been 
shown to mediate interactions with other proteins or possess additional 
enzymatic activities (e.g. N-terminus of WRN protein contains an exonuclease 
domain) (174). 
Biochemical studies have shown that RecQ family proteins are ATP- 
dependent helicases that separate duplex DNA with a 3’5’ polarity (175). 
The processivity of DNA unwinding by RecQ helicases is relatively low in the 
absence of accessory factors such as ssDNA binding proteins. In contrast, the 
same enzymes are capable of migrating HJs over several kb of DNA. 
Additionally, it has been shown that many RecQ helicases exhibit an intrinsic 
DNA strand-annealing activity (184,188-192). A common property of RecQ 
proteins is their ability to bind and unwind DNA structures other than standard 
B-form DNA duplex. Preferred substrates are branched DNA structures, 
including forked structures, four-way DNA junctions, D-loops and G-
quadruplex DNA (175). This implicates that RecQ helicases function in 
cellular processes where such DNA structures arise that is DNA replication 
and recombination. 
 
3.5.4.1 E. coli RecQ 
Compared to other RecQ family members, the E. coli RecQ helicase shows a 
much wider substrate specificity in vitro. Apart from unwinding duplex DNA 
with a 3’-ssDNA tail, different fork structures, HJs, G-quadruplex DNA and D-
loops, E. coli RecQ is also able to separate duplex DNA with a 5’-ssDNA tail 
and blunt-ended duplex DNA (193-196).  
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Figure 9 
Selected members of the RecQ familiy of DNA helicases. Regions corresponding to the 
helicase domain (DExH domain), zinc-binding motif (Zn), and winged-helix domain (WH) are 
indicated and collored accordingly to the domains in the cartoon of crystal structure of E. coli 
RecQC (178), shown on the right. In addition, the helicase and RNaseD C-terminal domain 
(HRDC) as well as the location of the putative nuclear localization signals (black line) (193) 
are indicated. 
 
 
RecQ is suggested to have multiple biological functions in the bacterial 
cell. Controversially, some of them may lead to opposing effects. For 
example, RecQ functions in the initiation of HR, but can also suppress 
illegitimate recombination. RecQ is a member of the RecF recombination 
pathway, which includes RecA, RecF, RecG, RecJ, RecO, RecR and 
RuvABC, and mediates recombination on DNA substrates that lack a DSB, 
including gaps and nicks. RecQ is proposed to act at the initiation phase of 
this HR pathway by generating ssDNA for assembly of the RecA filament. 
RecQ helicase is capable to initiate RecA-catalyzed homologous pairing and 
strand-exchange reactions from duplex DNA substrates in vitro (195). In vivo, 
it appears likely that RecQ in conjunction with RecJ degrades the nascent 
lagging strand at stalled replication forks (105) allowing either fast repair (104) 
or induction of DNA damage signaling, called SOS response (196). The 
ssDNA generated by RecQ/RecJ at the fork serves as substrate for RecA 
filament formation that is, besides catalyzing strand exchange, required for 
SOS response via proteolysis of the transcription repressor LexA and 
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consequent induction of several stress genes (196). In a recent study, RecQ 
was demonstrated to promote the formation of HR intermediates in vivo (198). 
Cells defective for HJ resolution (ruv) and anti-recombinase (uvrD) 
accumulated toxic recombination intermediates and displayed failed 
chromosome segregation. Viability of these ruvB uvrD double mutants could 
be restored by inactivation of recQ, recF or recA (198). On the other hand, 
RecQ was reported to act as an anti-recombinase. RecQ is capable to disrupt 
recombination intermediates, including D-loops in vitro (195) and suppresses 
illegitimate recombination between DNA sequences with limited homology 
(199). 
E. coli RecQ cooperates with the topoisomerase III (Top3). This 
functional coupling seems conserved among several RecQ family proteins 
and the RecQ-Top3 pairs appear to conduct an important role in maintaining 
genome stability. E. coli RecQ stimulates strand-passage activity of Top3 in 
vitro (200). If E. coli RecQ-Top3 functions in a similar way as human BLM-
TOPOIII, which mediate double Holliday junction (DHJ) dissolution, is not yet 
clear. A recent study also suggested that the RecQ-Top3 complex could be 
involved in resolution of converging replication forks (201). 
 
3.5.4.2 S. cerevisiae Sgs1 
Slow growth suppressor 1 (Sgs1) is the sole RecQ helicase in budding yeast. 
Biochemical analysis has been carried out with a N- and C-terminally 
truncated protein designated Sgs1400-1268. The enzymatic properties of this 
recombinant protein are similar to those of the other RecQ helicases. Sgs1400-
1268 can unwind, in an ATP-dependent manner, duplex DNA with a 3’-ssDNA 
tail, three- and four-way DNA structures and G-quadruplex DNA. In addition, it 
is able to disrupt RNA/DNA duplexes (202-205). 
Sgs1 expression is cell cycle regulated. It is very low in the M and G1 
phase, peaks in S phase and decreases again in G2 (206). Sgs1 strains are 
sensitive to UV light, methylmethane sulfonate (MMS) and HU and display 
intra- and inter-chromosome hyper-recombination, as well as an elevated 
frequency of SCEs (174). 
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Sgs1 appears to play multiple roles in DNA metabolism. Its function is 
coupled to all three topoisomerases (Top1, Top2, Top3) expressed in S. 
cerevisiae.  A genetic interaction between Sgs1 and Top1 was reported (207). 
Sgs1 was further identified in a search for Top2 interaction partners (208) and 
mutation in the SGS1 gene was found to suppress the top3 slow-growth 
phenotype (209). Sgs1 forms a complex with Top3 (210) and Rmi1/Nce4 
protein (211,212) that has been proposed to process HJs in the same manner 
as the human BLM-TOPOIII complex to suppress crossover during DSB 
repair (213). Consistent with the proposed DHJ dissolution activity of Sgs1-
Top3, sgs1 mutants accumulate Rad51-dependent recombination 
intermediates during a perturbed S phase (214). Further evidence that Sgs1 
has a role in removing HR intermediates is demonstrated by the synthetic 
lethality of sgs1 srs2 double mutants that is suppressed by mutation in Rad51 
(58). As mentioned above, Srs2 is suggested to act as anti-recombinase 
through disrupting other HR intermediates, namely Rad51 presynaptinc 
filaments (chapter 3.5.3) or eventually channeling HR into the SDSA pathway 
(56). 
Furthermore, Sgs1 is implicated to act at stalled replication forks. Sgs1 
is required for the stabilization of the replisome in HU treated cells. In its 
absence, Pol  and Pol  fail to remain associated with the fork and, as a 
consequence, the reestablishment of replication is impaired (215,216). 
Further evidence that Sgs1 could modulate the replisome function comes 
from analysis of DNA replication in sgs1 mutant cells. Surprisingly, in the 
absence of Sgs1, fork progression was faster as measured by DNA combing 
(217). However, in absence of Sgs1, completion of DNA replication was 
strongly retarded at the rDNA array, presumably because recombination takes 
place at naturally pausing sites when replisome is not stabilized (217).  
Sgs1 plays a role in S phase checkpoint that monitors DNA integrity. In 
HU treated cells, activation of the effector kinase Rad53 depends on Sgs1 in 
addition to a parallel signaling pathway via Rad17/Rad24 (206). Hence, rad24 
sgs1 double mutants have a severely compromised intra S phase checkpoint 
and fail to suppress late-origin firing in the presence of DNA damage (206). In 
addition a synthetic lethality is observed in the double mutants mus81 sgs1 
 38
and mms4 sgs1 (218), suggesting a bypass pathway via the nuclease 
complex Mus81-Mms4 in the absence of Sgs1-Top3. (219). 
 
3.5.4.3 Human RECQ1 
Of the five human RecQ helicases RECQ1 (also RECQL or helicase Q1) is 
the smallest. Purified RECQ1 is a 3’5’ helicase of rather low processivity. 
On its own it is capable to unwind only short M13 partial duplex DNA of less 
than 30bp (220). However, addition of human RPA stimulates its unwinding 
activity specifically allowing duplex-substrate separation of more than 500bp 
in length (221). Further biochemical analysis demonstrated that RECQ1 could 
unwind a wide variety of DNA structures, including fork structures, HJs, and 
D-loops (191). As the other human RecQ proteins, RECQ1 can catalyze 
annealing of short complementary DNA strands in a reaction that is 
modulated by ATP binding (191). The balance between the two opposing 
functions, DNA unwinding and annealing, is proposed to be linked to the 
oligomeric state of RECQ1 (222). In the absence of ATP, RECQ1 is 
assembled into ring-like oligomeric structures of five or six subunits and 
capable to promote strand annealing. Addition of ATP or ATPS results in the 
disruption of higher oligomeric structures and allows strand-separation 
reaction by dimeric or monomeric RECQ1 (222). 
The cellular function of RECQ1 is not yet clear. RECQ1 is the most 
abundant RecQ helicase in human cells (223), but mutations in RECQ1 are 
not linked to a human disease condition. Recent data indicate a potential role 
of RECQ1 in genome maintenance. Recq1-knockout mice do not show 
particular abnormalities, but cells from these mice showed an elevated 
frequency of chromosomal instability (193). Furthermore, RECQ1 was shown 
to interact with mismatch repair factors MSH2-MSH6 and exonuclease 1 (224) 
and identified as the major HJ processing enzyme in HEK293 cell nuclear 
extract (225). 
 
3.5.4.4 Human BLM 
The Bloom syndrome helicase (BLM) is one of the most intense studied 
human RecQ family member. Loss of BLM function causes a rare autosomal 
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recessive disorder called Bloom’s syndrome (BS). The BS phenotype is 
multifaceted and is generally associated with death before the age of 30 
(172). Affected individuals show growth retardation, impaired fertility, immune 
deficiency and a dramatic predisposition to development of most cancer types 
(173,174). Genomic instability is proposed to drive tumorigenesis in BS (173). 
Cells from BS patients show DNA gaps, breaks and structurally rearranged 
chromosomes at an elevated frequency. However, the hallmark feature of BS 
cells, which is used in diagnosis in humans, is the approximately 10-fold 
increase in the frequency of SCEs (174). In addition, BS cells are reported to 
be sensitive to DNA damaging agents such as UV light and HU, but not to -
irradiation (174). A viable mouse model for BS has been established (226). 
BLM-deficient mice are cancer prone; cell lines from these mice display an 
elevated rate of mitotic recombination and a high frequency of somatic loss of 
heterozygosity (147), which helps to explain how BLM could suppress 
tumorigenesis (226). 
Purified human BLM was demonstrated to form hexameric and 
tetrameric ring structures in solution (227), which is mediated by the N-
terminal part of the protein that is not important for the helicase activity of the 
enzyme (228). A BLM core fragment (aa 642-1290) that lacks this domain 
exists as a monomer and exhibits similar DNA unwinding activity as full-size 
BLM (229). In vitro, BLM helicase alone is capable to unwind DNA duplexes 
up to 70bp in length, but can be stimulated to unwind up to 300bp by 
association with RPA (230). Like other RecQ helicases, BLM is active on 
aberrant DNA molecules (231), catalyzing efficiently disruption of D-loops 
(14,232), G-quadruplex DNA (205,233), HJ-branch migration (234) and is able 
to promote the regression of a model replication fork (129). Besides 
unwinding activity, BLM also displays a ssDNA annealing activity in vitro 
(188,190). 
BLM is expressed in all tissues where cell proliferation takes place. The 
BLM protein level is very low in G1 and peaks in S/G2 phase of the cell cycle 
(174). BLM is generally found in PML nuclear bodies, large nuclear structures 
that are defined by the presence of the promyelocytic leukemia (PML) protein. 
The function of those PML nuclear bodies is not yet clear and they are 
proposed to represent a protein storage depot (235). Exposure of cells to 
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DNA damaging agents or replication inhibitors causes relocalization of BLM to 
sites of ongoing DNA repair (236,237). Under such conditions, BLM co-
localizes with several other proteins that are required for DNA repair, including 
RPA, RAD51, BRCA1, and the MRN complex. BLM is found in multi-protein 
complexes in the cell and makes numerous contacts with other DNA repair or 
DNA damage signaling proteins (172,174). A selection of those proteins is 
shown in Figure 10. 
BLM is recruited to sites of stalled replication forks in cells treated with 
HU (238). Analysis of chromosome fibers revealed that BLM-defective cells 
are compromised in replication-fork restart after HU and aphidicolin treatment 
as well as in suppression of new origin firing (239). Recent findings suggested 
mechanisms for how BLM could suppress excessive mitotic HR and thereby 
counteract genome instability. BLM was shown to be very efficient in 
displacing the invading strand of mobile D-loop structures in vitro (232). 
However, when RAD51 was bound to D-loop substrates, BLM was only 
capable of disrupting those structures after inactivation of the RAD51 filament 
by removal of Ca2+ ions (170). In addition, it was demonstrated that BLM is 
able to displace human RAD51, but not yeast Rad51, from ssDNA, thus BLM 
may inhibit the initial strand invasion step of HR (170). Furthermore, BLM in 
complex with TOPOIII and BLAP75/RMI1 is proposed to act late in HR 
pathway by processing of DHJs (240,241). In biochemical experiments, BLM-
TOPOIII was demonstrated to resolve DHJs exclusively into non-crossover 
products (52). The catalysis of this reaction is highly specific for BLM 
(187,240) and may explain how loss of BLM function leads to increased  
 
 
Figure 10 
Selected protein partners of BLM and 
WRN. The helicase, RecQ-Ct and 
exonulease domains are shown as green, 
orange and blue boxes, respectively. All 
proteins indicated interact with BLM and/or 
WRN. Horizontal arrows indicate 
approximately limits of binding domains for 
proteins whose interaction sites have been 
mapped less accurately. Adapted from 
(172). 
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frequency of SCEs in BS patients. Recently, it has been shown that BLM- 
TOPOIII and BLAP75/RMI1 are localized to ultrafine anaphase bridges, 
suggesting a role for BLM in decatenation of chromatid disjunctions during 
anaphase (242). 
 
3.5.4.5 Human WRN 
The Werner syndrome helicase (WRN) is another RecQ member implicated in 
human disease. Germ line mutation in WRN gene gives rise to Werner’s 
syndrome (WS), an autosomal recessive disorder associated with multiple 
progeroid pathologies and a greatly increased cancer incidence (173). 
Individuals with WS are phenotypically normal until puberty, at which time 
they fail to show the usual growth spurt. Consequently, affected individuals 
are of short stature and start to develop a battery of symptoms that are 
normally seen only in the elderly people, including skin changes, hair loss, 
osteoporosis, cataracts and arteriosclerosis (174). Death usually occurs 
before the age of 50 due to vascular diseases or cancer, with a high rate of 
mesenchymal malignancies being observed (172). 
WRN is unique among all RecQ proteins in having an N-terminal 
exonuclease domain whose structure has been recently determined (243). 
Biochemical analysis showed that WRN possesses both 3’5’ exonuclease 
activity (244,245) and ATP-dependent 3’5’ helicase activity (246,247). WRN 
nuclease functions on a variety of DNA substrates, including DNA bubbles, 
stem-loops, forks and HJs, as well as on RNA-DNA duplexes (248). WRN 
helicase shows low processivity. On its own, it can unwind DNA duplexes up 
to about 70bp in length, but in the presence of RPA it can catalyze unwinding 
of longer duplex DNA substrates up to 849bp (249). Preferred substrates for 
WRN helicase are DNA bubble structures, forked DNA and G-quadruplex 
DNA (231). WRN is capable of promoting branch migration of HJs (250), 
displays fork-regression activity (130) and ssDNA annealing activity (188). 
Expression of WRN is cell cycle regulated, being the highest in G2/M 
phase (174). Cells from WS patients show an increased frequency of 
chromosomal rearrangements, including translocations, inversions, and manly 
extensive deletions, but no elevated frequency of SCEs (174). Furthermore, 
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WS cells show a reduced ability to proliferate, which may be one of the 
underlying reasons for premature aging observed in WS patients (173). 
A role for WRN in DNA replication has been proposed. WRN was 
reported to interact with proteins required for DNA replication, such as RPA, 
PCNA, FEN1 and Pol  (Fig. 10) (172,174). In vitro, WRN was shown to assist 
DNA Pol  to catalyze DNA synthesis through G-quadruplex structures (251). 
Cells lacking WRN helicase were reported to be defective in lagging-strand 
synthesis of the G-rich template strand of telomeres (252). It appears that 
WRN plays an important role in the maintenance of telomere structure. WS 
cells with compromised DNA damage response rapidly accumulate 
chromosome fusions that can be rescued by either expression of WRN or 
telomerase (253). Evidence for the function of WRN in telomere metabolism 
comes also from the mouse model for WS. The WS phenotype in Wrn-/- mice 
only manifests when the mice also lack telomerase (254).  
There are further potential roles for WRN. For example, WRN may be 
involved in NHEJ through its direct contact with Ku70/80 (174). It can also 
participate in BER via interaction with Pol  (255). It also interacts physically 
and functionally with the MMR factors MutS, MutS, and MutL, suggesting 
a role in rejection of recombination between divergent sequences (256). A 
role in HR is possible since abnormal recombination intermediates 
accumulate in WS cells that can be resolved by expression of the bacterial HJ 
resolvase RusA (257,258). 
 
3.5.4.6 Human RECQ4 
There are three autosomal recessive disorders associated with mutations in 
the RECQ4 (also RECQL4) gene: Rothmund-Thomson syndrome (RTS), 
RAPADILINO syndrome and Baller-Gerold syndrome (BGS) (173,259). The 
three syndromes are rare and phenotypically complex showing some 
overlapping symptoms such as short stature and skeletal abnormalities. 
Poikiloderma is characteristic for RTS and BGS whereas joint dislocation is 
mainly seen in RAPADILINO syndrome. RTS patients display premature 
aging symptoms and a predisposition to malignant tumors, particularly 
osteosarcomas. 
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RECQ4 protein lacks the RecQ-Ct domain. Accordingly, RECQ4 does 
not show conventional DNA helicase activity although it is proficient in 
promoting ATP hydrolysis in the presence of ssDNA (189). It also possesses 
a strong ssDNA annealing activity residing in the N-terminal part of the protein 
(189,192). Interestingly, a recent study demonstrated that in the presence of 
excess complementary ssDNA, RECQ4 can mediate DNA duplex unwinding 
in a manner dependent on ATP. The authors suggested that under classical 
helicase conditions, the strong intrinsic DNA annealing activity of RECQ4 
might mask its unwinding activity (192). Paradoxically, RECQ4 Walker A and 
Walker B mutants were still able catalyzing DNA duplex unwinding. An 
additional helicase activity that resides in the N-terminal RECQ4 domain may 
explain this finding (192). 
Cells derived from RTS patients show genomic instability, including 
aneuploidy (e.g. trisomy 8) and chromosomal rearrangements (173). How 
RECQ4 prevents genomic instability as well as the molecular pathways in 
which it might be involved remain poorly understood. A potential role in the 
initiation of DNA replication has been suggested by recent studies using 
Xenopus laevis egg extracts. It has been shown that immunodepletion of 
xRTS protein results in a reduction and delay in sperm chromatin replication, 
an effect that can be rescued by complementing the extracts with recombinant 
human RECQ4 (260). In addition, the following interaction partners of RECQ4 
were reported: RAD51 (261); UBR1/2 ubiquitin ligases (262); and poly(ADP-
ribose)polymerase 1 (263). 
 
3.5.4.7 Human RECQ5 
The human RECQ5 protein exists in at least three different isoforms, 
RECQ5, RECQ5 (here RECQ5), and RECQ5, resulting from alternative 
splicing of the RECQ5 transcript (Fig. 9) (264,265). The two short isoforms, 
RECQ5 and RECQ5 lack the zinc-binding motif, and in a recent 
biochemical analysis RECQ5 failed to exhibit DNA-dependent ATPase and 
helicase activity (183). In agreement with these results, the zinc-binding motif 
has been shown to be important for DNA binding, ATPase and helicase 
activities of the E. coli RecQ (181) and human BLM (182). The largest isoform 
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RECQ5 contains the zinc-binding motif and exhibits ATP-dependent 3’5’ 
helicase activity (184). Like other RecQ helicases, RECQ5 is a helicase with a 
low processivity that is stimulated in its unwinding capacity by RPA and 
possesses an intrinsic ssDNA annealing activity (184). RECQ5 functions 
probably as a monomer and acts on forked substrates and HJs (131,184).  
RECQ5 gene is expressed throughout the cell cycle in normal human 
fibroblast cell lines (223). In contrast to the other human RecQ members, 
RECQ5 protein is also expressed in resting G0 cells (223). Only the large 
isoform, RECQ5, harboring a potential nuclear localization signal in its C-
terminal domain, is found in the nucleus (131,265). RECQ5 and RECQ5 
were found in the cytoplasm if expressed as fusions with GFP (265). At 
present, no human disease has been linked to mutation in the RECQ5 gene. 
Recq5-knockout mice have been generated (266). These mice do not show 
particular abnormalities, but they are prone to cancer development (169,266). 
Cells from these mice exhibit an increased frequency of RAD51 foci and gross 
chromosomal rearrangements after camptothecin treatment, but an increase 
in the frequency of LOH was not obvious (169). Moreover, Recq5-/- mouse 
embryonic stem (ES) cells showed a mild slow growth phenotype and a 
significantly higher frequency of SCEs compared to wild-type cells, a 
phenotype similar to Blm-/- cells (266). Interestingly, the rate of SCEs in the 
Recq5 Blm double-knockout cells was even higher than that in either single 
mutant, suggesting that RECQ5 and BLM operate in different pathways to 
suppress mitotic recombination (266). In chicken DT40 cells, Recq5 deletion 
did neither manifest in slow growth phenotype nor in an increase in the 
frequency of SCEs (267). But again, the rate of SCEs in Recq5-/- Blm-/- double 
mutant DT40 cells was much higher than that in Blm-/- cells (267). 
RECQ5 interacts with RAD51 in vivo and in vitro and can disrupt 
RAD51 presynaptic filaments in a reaction dependent on ATP hydrolysis and 
the presence of RPA, suggesting a mechanism for how RECQ5 regulates HR 
(169). There is also evidence that RECQ5 assists during DNA replication. 
RECQ5 associates with the replication machinery and accumulates at sites of 
stalled replication forks and DSBs (131,268). RECQ5 is linked to sites of DNA 
damage via its interaction with the MRN complex (268). Other protein 
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interactions with potential biological relevance were reported for RECQ5: for 
example, interaction with TOPOIII and  (265), and with the RNA Pol II 
complex (269,270). In Figure 11, selected interaction partners of RECQ5 
identified in our laboratory and the cellular processes in which they are 
involved are shown. 
 
 
Figure 11 
Selected interaction partners of RECQ5. Methods used to identify protein-protein 
interactions are given as following abbreviations: IP-MS/WB, Analysis of RECQ5 
immunoprecipitate from 293T cell extracts by mass spectrometry/Western blot; YTH, yeast 
two hybrid assay. 
 
 
 
 
 
 
 
 
 
 
 46
4 AIM OF MY STUDIES 
RecQ DNA helicases are involved in processing of complex DNA structures 
arising during DNA metabolism and prevent excessive mitotic recombination 
that can destabilize the genome. Like other RecQ family members, the human 
RECQ5 protein is proposed to act during DNA replication and repair. 
However, its exact role in these processes has not yet been clearly defined. 
The main objectives of my PhD project are: 
(i) to characterize the activity of RECQ5 on DNA structures that 
resemble stalled replication forks and  
(ii) to elucidate the mechanism underlying RECQ5-mediated disruption 
of RAD51 nucleoprotein filaments that initiate homologous DNA 
recombination. 
 In the first study, we further characterized the strand-exchange activity 
of RECQ5 observed with oligonucleotide-based forked DNA structures. We 
tested if RECQ5 can promote regression of a M13-based model DNA that 
mimics a stalled replication fork with a leading-strand gap. In the second 
study, we asked whether physical interaction between RECQ5 and RAD51 is 
required for RECQ5-mediated displacement of RAD51 from ssDNA. To 
address this issue, we mapped precisely the RAD51-interaction domain on 
RECQ5 and tested RECQ5 mutants that fail to interact with RAD51 in a 
topoisomerase-linked RAD51-trap assay for the ability to disrupt RAD51 
filaments. 
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5 RESULTS 
 
5.1 Characterization of fork-regression activity of RECQ5 
The human RECQ5 protein has been shown to possess three distinct 
biochemical activities: a 3’5’ DNA unwinding activity, a ssDNA annealing 
activity and a Holliday junction (HJ) branch migration activity (184). It is not 
yet clear whether all three activities are relevant or even coordinated for 
RECQ5 function. A DNA transaction that could be promoted by the three 
mentioned catalytic activities is replication-fork regression. In this process the 
arms of the replication fork are unwound, the parental strands are repaired 
and the nascent strands are annealed to form a HJ-like structure that can be 
stabilized by branch migration. Recently, RECQ5 has been shown to promote 
strand exchange between homologous arms of a synthetic forked DNA 
structure (131). The DNA substrate used in this study was assembled from 
oligonucleotides and had arms with length of 30nt. Furthermore, in the same 
study it was demonstrated that RECQ5 preferentially unwinds the lagging-
strand arm of a synthetic forked DNA structure with non-complementary arms. 
In contrast, BLM and WRN unwind preferentially the parental duplex. In 
addition, RECQ5 was suggested to be present at replication forks through 
physical interaction with proteins of the DNA replication machinery, like PCNA 
(131) and MCM proteins (unpublished data). These findings let us to test the 
hypothesis that RECQ5 promotes replication-fork regression, hence could act 
in the recovery of damaged replication forks. For testing the fork-regression 
activity of RECQ5, we used a large M13-based forked DNA structure that 
allows trapping intermediates of the fork-regression reaction containing HJ. 
 
5.1.1 DNA structures for fork-regression assay 
For testing fork-regression activity of RECQ5, we used a modified version of a 
biochemical assay previously established for testing fork-regression activity of 
the bacterial proteins RecA and RecG (111,116). The DNA structures used in 
this assay mimic a stalled replication fork with a ssDNA gap (of 2.1kb or 
0.2kb) on the leading-strand arm. These branched DNA structures consisted 
of a gapped duplex (gd) DNA circle and a homologous DNA arm ligated to the  
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Figure 12 
Preparation of DNA substrate for fork-regression assay. (A) The structure of the DNA 
substrate used for testing fork-regression activity of RECQ5. The structure mimics a stalled 
replication fork with a leading-strand gap: the arm fragment represents the lagging-strand 
arm; the parental duplex and the leading-strand arm are linked. The indicated MscI sites are 
the cleavage sites used to generate a linear fork structure. The components used to construct 
this structure are: (a) gd DNA (7.3kb circle with a 2.1kb or 0.2kb ssDNA gap); (b) homologous 
dsDNA arm (7.3kb), and (c) a linker DNA (annealed oligo1MP (49-mer) and oligo 2M (30-
mer)). (B) Schematic illustration of the preparation of DNA substrate. (C) DNA species from 
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individual steps of substrate preparation resolved by agarose gel electrophoresis. Lanes 1-4: 
gd DNA was prepared by a RecA-mediated strand-exchange reaction between circular 
M13mp8.32 ssDNA and a defined homologous linear dsDNA fragment (shown here for 
M13mp8.32 5.2kb-[BsrGI-EcoRI] fragment). Lanes 5-8: The structure of the gd DNA was 
verified by restriction analysis. The recognition sites of the used enzymes are indicated in the 
scheme on the right. Lanes 9-12: The branched DNA substrate was assembled from the 
purified gd DNA and the homologous arm fragment (M13mp8.32 7.3kb-[SapI-SmaI]) using 
the linker DNA described above. Lane 13-19: MscI-linearized substrate before and after gel 
purification (lanes 19 and 18, respectively) and known amount of linearized M13mp8.32 
dsDNA used to estimate branched substrate concentration (lanes 14-17). M, 1kb DNA ladder 
(New England Biolabs); gd, gapped duplex DNA; ss, circular single-stranded DNA; ds, linear 
dsDNA fragment; a, homologous arm fragment already ligated with the linker DNA; s, circular 
branched DNA substrate; ls, MscI-linearized substrate; Lin. M13 DNA, linearized M13mp8.32 
dsDNA. 
 
 
free 5’-end of gd DNA through a synthetic linker (Fig. 12 A) (116). The gd 
DNA was generated by a RecA-mediated strand-exchange reaction between 
circular M13mp8.32 ssDNA and a defined dsDNA fragment generated by 
restriction-enzyme digestion of the ds form of M13mp8.32 DNA (Fig. 12 B and 
C lanes 2-4). The structure of the gd DNA was verified by restriction analysis 
(Fig. 12 C lanes 5-8). The homologous linear arm fragment was also prepared 
from M13mp8.32 DNA by restriction-enzyme digestion. It was ligated to 
purified gd DNA in two successive reactions. Firstly, we ligated a synthetic 
linker that consisted of two annealed oligonucleotides to the linear arm 
fragment. Secondly, the purified linker-arm fragment could be annealed and 
ligated with the gd DNA via a 16-nt overhang of the linker DNA that was 
complementary to the 5’-proximal end of the gd DNA (Fig. 12 B and C lanes 
10-12). The linker DNA contained six heterologous bases with respect to the 
M13mp8.32 sequence at the positions 1,2,3,6,9 and 12 from the fork junction 
to prevent spontaneous branch migration. The DNA structure for fork-
regression assay was usually linearized by MscI and purified by agarose gel 
electrophoresis followed by electroelution (Fig. 12 B and C lanes 18 and 19).  
 
5.1.2 Analysis of fork-regression activity of RECQ5 
The fork-regression reaction with the above-described branched DNA 
structure is shown in Figure 13 A. On such structures, fork regression 
includes unwinding of the lagging-strand arm, migration of the branch point 
towards the 3’-end of the ssDNA gap, annealing of the liberated strands to 
form a HJ-like structure and finally migration of this four-way DNA junction 
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unidirectionally to complete strand exchange. For the circular branched 
structure, the ssDNA region is transferred to the end of the dsDNA arm (Fig. 
13 A). For the linearized structure, the fork-regression end-products are two 
linear DNA fragments (Fig. 13 A). 
 To test fork-regression activity of RECQ5, we first used linearized DNA 
structures containing a 2.1kb or a 0.2kb leading-strand gap. In addition to 
wild-type RECQ5, an ATPase-defective RECQ5K58R mutant and the 
bacterial helicase RecG were used in these assays as negative and positive 
controls, respectively. The fork-regression products were analyzed by 
agarose gel electrophoresis and Southern blotting using 32P-labeled probes 
complementary to the DNA region indicated in red (Fig. 13 B). RecG has been 
described to promote efficiently regression of such a forked DNA structure in 
vitro (111). In our assay, RecG converted both DNA substrates into the 
expected linear 7.3kb products (Fig. 13 B lanes 6 and 13). With RECQ5, we 
could observe complete disappearance of the substrate in the presence of 
ATP (Fig. 13 B lanes 2 and 9), but not in the presence of the poorly 
hydrolysable ATP analog ATPS (lanes 3 and 10) or in a reaction without 
nucleotide co-factor (lanes 4 and 11). These findings indicated that RECQ5 
processed the DNA substrates in a helicase-dependent manner, which was 
further confirmed using the ATPase-defective RECQ5K58R mutant that 
showed no activity in the assay (Fig. 13 B lanes 5 and 12). In contrast to the 
RecG-promoted reactions, a clear increase in the linear 7.3kb product was not 
observed with RECQ5 (Fig. 13 B compare lanes 2 to 6 and 9 to 13) indicating 
that RECQ5 may not promote the regression reaction unidirectionally for more 
than 6kb, which is required to generate the linear end products.  
 
5.1.3 Restriction analysis of the fork-regression products  
Next, we employed restriction enzymes to be able to monitor the formation of 
early regression intermediates. We used three different restriction enzymes, 
namely HindIII, PvuI and BglII, having recognition sites in the lagging-strand 
arm of the forked DNA substrate (Fig. 14 A). These sites are transferred into 
the parental arm by fork regression. Therefore, digestion of fork-regression 
intermediates with these enzymes will give rise to defined linear duplex 
fragments if the fork junction has moved beyond the site of cleavage. 
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Figure 13 
Fork-regression activity of RECQ5. (A) Schematic of fork-regression reaction with circular 
or MscI-linearized fork structure containing a leading-strand gap. See text for explanations. 
(B) Processing of forked DNA structures with a 2.1kb or a 0.2kb leading-strand gap by 
RECQ5 depends on ATP hydrolysis. About 10 pM linearized DNA substrate was incubated 
with 100 nM RECQ5, 100 nM RECQ5 K58R or 40 nM RecG as indicated in the presence or 
absence of 2 mM nucleotide co-factor ATP or ATPS for 30 min at 37°C in 1 x NEB4 buffer 
supplemented with 50 μg/ml BSA. The reaction products were deproteinized, separated by 
0.7% agarose gel electrophoresis and transferred to a Zeta-Probe membrane by Southern 
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blotting. DNA was visualized by autoradiography using 32P-labeled probes specific for a 1.2kb 
region of the DNA molecule indicated in red. M, M13mp8.32 linear duplex DNA of 7.3kb, 
5.2kb and 1.2kb lengths; S2.1kb and S0.2kb, substrate with 2.1kb and 0.2kb leading-stand gap, 
respectively. 
 
 
Appearance of HindIII, PvuI and BglII linear duplex fragments indicates that 
the fork junction has regressed more than 40bp, 170bp or 700bp, 
respectively. When RECQ5 was incubated with the forked substrate 
containing a 2.1kb leading-strand gap, followed by restriction-enzyme 
digestion, we could detect all three linear fragments both in the absence and 
the presence of RPA (Fig. 14 lanes 5,6,9,10,13,14). This indicates that 
RECQ5 could promote fork regression through a region of at least 0.7kb. As 
judged from the intensity of the linear fragments, RPA appeared to slightly 
stimulate the regression reaction (Fig. 14, compare lanes 6,10 and 14 to lanes 
5, 9 and 13). 
 Next, we investigated if RECQ5 could promote the regression of the 
forked substrate to form a four-way DNA junction. To detect the presence of 
the regressed arm, reaction products were digested with the restriction 
endonuclease AclI (Fig. 14 C). The AclI-dependent release of a characteristic 
regressed arm fragment and a 1.7kb duplex fragment could be detected for 
both RECQ5 and RecG in reactions with the forked substrate containing a 
0.2kb strand gap (Fig. 14 Di lanes 4,5). Formation of the AclI restriction 
fragments was dependent on RECQ5 protein concentration (Fig. 14 Dii). 
Again, RPA appeared to slightly stimulate the reaction judged by the intensity 
of the 1.7kb fragment that represents the re-annealed parental strands (Fig. 
14 Dii, compare 1.7kb bands in lanes 4-8 to lanes 10-14). However, RPA 
seemed to interfere with annealing of the liberated nascent strands since the 
intensity of the regressed arm fragment was weaker in reactions where RPA 
was included (Fig. 14 Dii, compare regressed arm fragment to 1.7kb band in 
lanes 4-8 to lanes 10-14). 
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Figure 14 
Restriction analysis of fork-regression products of RECQ5. (A) Schematic of the fork-
regression reaction with the forked structure containing a 2.1kb leading-strand gap. HindIII, 
PvuI and BglII recognition sites are indicated on the substrate, early regression intermediate 
and end product. H, HindIII; P, PvuI; B, BglII. (B) RECQ5 promotes fork regression through a 
long leading-strand gap. The Southern blot shows DNA products after fork-regression assay 
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and restriction-endonuclease cleavage. About 10 pM of the linearized substrate containing a 
2.1kb leading-strand gap was incubated with 40 nM RECQ5 and 40 nM RPA as indicated at 
37°C in 1 x NEB4 buffer supplemented with 2 mM ATP and 50 μg/ml BSA for 1h, followed by 
a further 2h incubation with the restriction enzymes: HindIII (10 U), PvuI (3.5 U), BglII (7 U). 
Reaction products were analyzed as described in Figure legend 13 B. The 1.2kb DNA region 
recognized by the 32P-labeled probes is indicated in red. M, M13mp8.32 linear duplex DNA of 
7.3kb, 5.2kb and 1.2kb lengths; C, control linear duplex fragments of 1.9kb, 1.3kb or 1.2kb 
lengths. (C) Schematic of fork-regression reaction with indicated AclI sites on substrate, four-
way DNA intermediate and end products. (D) RECQ5 promotes regression of forked DNA 
structure to generate a four-way junction. Fork-regression assays were carried out with a 
linearized substrate containing a 0.2kb leading-strand gap. i) About 10 pM substrate DNA 
was incubated with 100 nM RECQ5 or 40 nM RecG as indicated for 30 min at 37°C, followed 
by an additional 30 min incubation with 1.5 U of AclI. ii) About 10 pM substrate DNA was 
incubated with RECQ5 (10, 20, 40, 80, 160 nM) with or without 20 nM RPA as indicated for 1 
h at 37°C, followed by an additional 1 h incubation with 3 U of AclI. The reaction products 
were analyzed as described above and DNA detected by 32P-labeled probes specific for a 
2.1kb region of the structure indicated in red. M, M13mp8.32 linear duplex DNA of 7.3kb, 
6.1kb, 5.1kb, 2.1kb and 1.7kb lengths and a control DNA c for regressed arm fragment 
composed of a duplex part and a long 5’-ssDNA overhang generated by cleavage of gapped 
duplex DNA with EcoRI and AclI; S0.2kb linearized substrate containing a 0.2kb leading-stand 
gap. Note a loading error in lane 3 of Dii). 
 
 
5.1.4 Monitoring fork regression by RusA cleavage 
In order to confirm that RECQ5 converts the forked substrate into a four-way 
DNA structure, we included the bacterial HJ-specific resolvase RusA in our 
assay. RusA binds to HJs and introduces two symmetrically orientated nicks 
at the junction (271,272). We first established RusA cleavage under RECQ5 
reaction conditions. The RusA protein was produced in bacteria, purified to 
homogeneity and tested for its activity on a plasmid-sized DNA containing a 
mobile HJ. This DNA was generated in vivo using the E. coli strain RM40 
transformed with the plasmid pSD115 containing two cer sites in direct 
orientation (273). Induction of XerC recombinase in this system leads to intra-
molecular recombination of the cer sites and results in a HJ-containing 
plasmid with two supercoiled domains resembling a figure 8. The plasmid 
DNA isolated from induced RM40 cells consisted of a mixture of pSD115 DNA 
in recombined, non-recombined and resolved conformations (Fig. 15 A). By 
EcoRI cleavage, HJ-containing pSD115 DNA was converted into an -
structure and this DNA molecule was purified (Fig. 15 A lane 2) and used to 
test RusA resolution activity. RusA resolved pSD115 -structure into a 2.35kb 
nicked circle and a 2.6kb linear fragment or a 4.95kb linear fragment 
depending on which pair of strands was cleaved (Fig. 15 B and C lane 2). 
Addition of ATP, ATPS or ssDNA oligonucleotide in large excess did not 
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affect significantly RusA resolution reaction (Fig. 15 C lanes 3-6). 
Furthermore, we could show that RusA can cleave HJs in the presence of 
RECQ5. RusA cleavage products were also formed after a 15 min pre-
incubation of -structure with RECQ5 (Fig. 15 C lanes 8 and 9).  
 Finally, we used RusA in our fork-regression assay to monitor the 
formation of four-way regression-intermediates of the circular substrate 
containing a 0.2kb leading-strand gap. RusA resolution of the regressed 
intermediates by cleavage in orientation a gives rise to a nicked circle and a 
7.3kb nicked linear fragment, whereas cleavage at orientation b produces a 
14.6kb nicked linear fragment (Fig. 15 D). All expected RusA-cleavage 
products were observed with RecG-promoted fork regression (Fig. 15 E lane 
9). However, we did not observe these products with RECQ5 (Fig. 15 E lanes 
3-8). This result challenges the earlier finding that regressed arm fragments 
observed by restriction analysis are formed by RECQ5-promoted fork 
regression. 
 
 
 
Figure 15 
Monitoring fork regression by RusA cleavage. (A) Preparation of Holliday junction (HJ)-
containing DNA. Plasmid DNA isolated from induced RM40/pSD115 cells was cleaved with 
EcoRI and subjected to electrophoresis in 0.9% agarose gel (lane 1). The isolated DNA is a 
mixture of the following species (scheme on the right): 4.95kb plasmid, HJ-containing 4.95kb 
plasmid formed in a XerC-promoted intra-molecular recombination reaction, and final Xer-
recombination product: 2.6kb and 2.35kb plasmids. pSD115 -structure (lane 2) was 
generated by EcoRI cleavage of one supercoiled domain of the HJ-containing plasmid and 
purified by agarose gel electrophoresis followed by electroelution. Lin, linear duplex DNA; , 
pSD115 -structure; , pSD115 -structure formed by breakage of the uncleaved domain of 
the -structure. (B) Schematic illustration of RusA cleavage of the pSD115 -structure. (C) 
RusA can cleave a HJ in the presence of RECQ5. RusA cleavage assay was carried out with 
about 20 pM pSD115 -structure in 1 x NEB4 buffer supplemented with 50 μg/ml BSA at 
37°C for 30 min. DNA was incubated with 10 nM RusA in the presence or absence of 2 mM 
ATP, 9 mM ATPS and 100 ng ssDNA (oligo f-10-C) as indicated. Lanes 7-9: DNA was pre-
incubated for 15 min with 50 nM RECQ5. Reaction products were deproteinized, separted by 
0.9% agarose gel electrophoresis, blotted to membrane and detected by autoradiography 
with 32P-labeled probes. For probe preparation the pSD115 0.95kb-[EcoRI-SalI] fragment was 
used. , -structure; nc, nicked circle. (D) Schematic diagram of RusA cleavage products 
arising during regression of a circular fork structure. (E) RECQ5 does not generate RusA 
cleavable fork-regression intermediates. About 10 pM circular substrate DNA containing a 
0.2kb leading-strand gap was incubated with increasing concentration of RECQ5 (5, 10, 20, 
40, 80, and 160 nM) or 40 nM RecG for 1 h at 37°C, followed by incubation with 5 nM RusA 
for 30 min in the presence of 100 ng ssDNA (oligo f-10-C) that served as a helicase trap. 
Reaction products were analyzed as described in Figure legend 13 B. For probe preparation 
the M13mp8.32 2.1kb-[EcoRI-BsrGI] fragment was used. 
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5.2 Analysis of the mechanism of RAD51 nucleoprotein-filament 
disruption by RECQ5  
Homologous recombination (HR) is an important mechanism for repair of DNA 
double-strand breaks (DSBs) and restoration of productive DNA synthesis 
following disruption of replication forks (33). This process must be tightly 
regulated since inappropriate and untimely HR events can destabilize the 
genome (71). RecQ helicases have a function in preventing excessive mitotic 
recombination. Also, RECQ5 is suggested to be involved in suppressing HR. 
Mouse cells deficient in the RECQ5 homolog exhibit an elevated level of 
spontaneous sister chromatid exchanges (SCEs) (266). In a recent study, it 
has been shown that the frequency and lifespan of RAD51 foci are increased 
in Recq5-/- mouse embryonic fibroblasts (MEFs) relative to normal cells and 
the repair by HR of a defined DSB in a reporter gene is 3.5-fold higher in 
Recq5-deficient embryonic stem (ES) cells than in wild-type ES cells (169). In 
the same study, a physical interaction between the human RECQ5 protein 
and the RAD51 recombinase was demonstrated in vitro and in vivo. 
Furthermore, RECQ5 was found to inhibit RAD51-mediated D-loop formation 
through displacement of RAD51 from ssDNA in a biochemical assay with 
recombinant human proteins (169). Therefore, the authors suggested that 
RECQ5 could prevent inappropriate HR events via RAD51 presynaptic 
filament disruption. 
 To date, several helicases have been reported to remove proteins from 
ssDNA. It is not clear whether this activity is specific for a target DNA-binding 
protein or if it is rather a side action that results from unidirectional 
translocation of a DNA helicase on ssDNA. In this study, we analyzed the 
mechanism of RECQ5-mediated RAD51 filament disruption, the suggested 
RECQ5 function to negatively regulate early step of HR. Especially, we 
investigated whether the physical interaction between RECQ5 and RAD51 is 
required for this activity of RECQ5. To address this issue, we first mapped 
accurately the RAD51-interaction site on RECQ5. Secondly, using a 
topoisomerase-linked RAD51-trap assay, we tested RECQ5 mutants that fail 
to interact with RAD51 for the ability to disrupt stable RAD51 filaments formed 
on ssDNA by an ATPase-defective mutant of RAD51. In addition, to analyze 
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the contribution of direct RAD51 binding to RAD51 filament-dissociation 
activity of RECQ5, we tested a BLM-RECQ5 chimera composed of the 
translocase part of BLM and the RAD51-interaction domain of RECQ5 and 
compared this fusion protein with a helicase-competent fragment of BLM and 
wild-type RECQ5 in the RAD51 filament-dissociation assay. 
 
5.2.1 Mapping of RAD51-interaction site on RECQ5 
In order to define the RAD51-interaction site on RECQ5, we performed affinity 
pull-down assays. Several N- and C-terminal truncation variants of RECQ5 
were constructed and expressed in bacteria as fusions with a chitin-binding 
domain (CBD) and bound to chitin beads (Fig. 16 A upper part). The beads 
were subsequently incubated with extract from 293T cells as source of 
RAD51 and RAD51 binding to beads was analyzed by Western blotting. The 
obtained data indicated that the RAD51-interaction domain of RECQ5 is 
located between amino acids (aa) 411-725 (Fig. 16 B). To map the location of 
this domain more precisely, we generated a series of internal deletions within 
the region of RECQ5 spanning aa 515-725 and tested the resulting mutants 
for the ability to bind to RAD51 in CBD pull-down assay (Fig. 16 A lower part). 
The obtained data indicated that the region spanning aa 515-653 is 
dispensable for RAD51 binding (Fig. 16 C lanes 4-7). In contrast, deletion of 
aa 652-674 as well as deletion of aa 652-725 of RECQ5 completely abolished 
its interaction with RAD51 (Fig. 16 C lanes 8 and 9). In addition, we found that 
a RECQ5 fragment containing aa 529-725 could bind RAD51 with affinity 
similar to that of full-length RECQ5 (Fig. 16 C compare lanes 3 and 10). 
Collectively, the above data suggest that RECQ5 contains a single RAD51-
interaction domain that is located between aa 654-725. 
 In an attempt to identify amino-acid residues of RECQ5 that are critical 
for RAD51 binding, we generated single alanine substitutions at charged and 
aromatic residues within the region spanning aa 654-674 that was established 
to be required for RAD51 binding. The following residues of RECQ5 were 
mutated: R654, F659, F666 and E671. The mutant proteins were again 
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expressed in bacteria as fusions with CBD and tested for binding to RAD51 
 
Figure 16 
Mapping of RAD51-interaction site on RECQ5. (A) Scheme of RECQ5 variants used in the 
CBD pull-down assay. The domains of RECQ5 indicated are: DExH helicase domain; Zn, 
zinc-binding motif; and PIM, PCNA-binding motif. The red and blue thick lines represent the 
used RECQ5 fragments and the numbers indicate the amino-acid (aa) boundaries. The aa 
stretch 654-725 is highlighted with a blue box. , deletion. (B) and (C): RAD51-interaction site 
on RECQ5 is localized between aa 654-725. The indicated RECQ5-CBD fusion variants over-
expressed in E. coli were bound to chitin beads, incubated with 293T cell extracts (B: 600 μg, 
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C: 800 μg) and bound RAD51 was analyzed by SDS-PAGE and Western blotting using anti-
RAD51 antibody (BD Pharmingen). (D) Phenylalanine 666 is critical for RAD51 binding. CBD 
pull-down assay was performed with the indicated RECQ5 point mutants expressed in E. coli 
and 293T cell extract (1 mg) as a source for RAD51. The presence of RAD51 was detected 
by Western blot analysis using the anti-RAD51 antibody from BD Pharmingen (lower panel). 
The use of similar protein amounts of the different RECQ5 variants was verified by Ponceau 
staining (upper panel). (E) F666 of RECQ5 is required for RECQ5-RAD51 complex formation 
in vivo. A Nickel pull-down assay was performed with extracts (800 μg) from 293T cells 
transfected with the expression vector for RECQ5, RECQ5652-674, RECQ5F666A, or the 
corresponding empty vector. The ectopically expressed RECQ5 variants harboring a C-
terminal (His)6-tag were immobilized on nickel beads and bound endogenous RAD51 was 
analyzed by SDS-PAGE and Western blotting using the anti-RAD51 antibody from BD 
Pharmingen (lower panel). Upper panel: membrane probed with anti-omni-probe antibody to 
visualize the (His)6-tagged RECQ5 variants. (F) RECQ5-RAD51 interaction is not mediated 
via DNA. Nickel pull-down assay was performed with extract (800 μg) from 293T cells 
transfected with the vector for wild-type RECQ5 or the corresponding empty vector. 
Expression and pull-down of (His)6-tagged RECQ5 was analyzed by SDS-PAGE and Western 
blotting using an anti-omni-probe antibody (upper panel). Co-precipitation of RAD51 was 
analyzed by an anti-RAD51 antibody (BD Pharmingen) (lower panel). Extracts pre-treated 
with DNaseI (20 U) are indicated. I, Input. 
 
 
from 293T cell extract. The data showed that the R654A and F659A 
substitutions in RECQ5 had no effect on its binding affinity to RAD51, while 
the F666A substitution completely abolished RAD51 binding and the E671A 
substitution reduced it significantly (Fig. 16 D). These data establish that 
phenylalanine 666 of RECQ5 is essential for binding of RECQ5 to RAD51 
(Fig. 16 D).  
 Next, we investigated whether mutational disruption of the RAD51-
interaction domain of RECQ5 defined by the above in vitro binding 
experiments affects RECQ5-RAD51 complex formation in vivo. For this 
purpose, 293T cells were transiently transfected with expression vectors for 
RECQ5, RECQ5652-674, or RECQ5F666A fused N-terminally to a (His)6-
tag. The ectopically expressed RECQ5 variants were bound to nickel beads 
via their N-terminal (His)6-tag and analyzed for co-precipitation of endogenous 
RAD51 by Western blotting. We found that only wild-type RECQ5 could bind 
RAD51; the two RECQ5 mutants failed to interact with RAD51 (Fig. 16 E). 
Furthermore, we showed that RECQ5-RAD51 interaction is not mediated via 
ss or dsDNA. Treatment of 293T cell extracts with DNaseI or addition of 
ethidium bromide did not affect the binding of RAD51 to wild-type RECQ5 
(Fig. 16 F and data not shown).  
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5.2.2 Establishment of RAD51 filament-dissociation assay 
To test the RAD51 filament-dissociation activity of RECQ5 mutants that do not 
bind RAD51, we employed a topoisomerase-linked RAD51-trap assay. A 
similar assay was previously established to characterize the presynaptic 
filament-disruption function of Srs2 (165) and recently applied to show RAD51 
filament-disruption function of RECQ5 (169). In this assay, RAD51 displaced 
from ssDNA is trapped by a plasmid DNA and monitored through topological 
changes in the plasmid DNA caused by RAD51 binding (Fig. 17 A). RAD51 
forms also a helical nucleoprotein filament on dsDNA and forces dsDNA to 
adopt an extended conformation (65,66). Therefore, RAD51 binding to 
topologically relaxed covalently closed circular dsDNA results in the formation 
of positive supercoils that can be monitored by treatment with eukaryotic 
topoisomerase I (165). In our experiments, pre-assembled RAD51 filaments, 
on circular ssDNA were mixed with RECQ5 and RPA (Fig. 17 A). After a brief 
incubation, an unrelated relaxed plasmid DNA was added to the reaction to 
trap the RAD51 molecules displaced from ssDNA. Positive supercoils in 
plasmid DNA induced by RAD51 binding were fixed upon incubation with 
wheat germ topoisomerase I and resulted in negatively supercoiling after 
proteinase K treatment (Fig. 17 A). The different DNA species present in the 
reaction: ssDNA, dsDNA in relaxed and supercoiled conformation, were 
separated by electrophoresis in agarose gel and visualized by ethidium 
bromide staining (Fig. 17 B Lanes 1-4). 
 Initially, we used wild-type RAD51 in this assay. No spontaneous 
transfer of RAD51 from ssDNA to dsDNA was observed (Fig. 17 B lane 4). 
With RECQ5, we could see concentration-dependent formation of supercoiled 
dsDNA products (lanes 5 and 6). However, the same products were observed 
with the ATPase-defective mutant of RECQ5 (RECQ5K58R) (lanes 7 and 8), 
suggesting that RAD51 filament is not stable and can be disrupted by any 
ssDNA-binding protein. This was further confirmed by the finding that E. coli 
ssDNA binding protein (SSB) as well as the human RPA could disrupt RAD51 
presynaptic filaments (data not shown). On the other hand, when the RAD51 
filament on ssDNA was assembled in the presence of the poorly hydrolysable 
ATP analog ATPS, it was stable and could not be disrupted by wild-type 
RECQ5 that still binds tightly to DNA under these conditions (data not shown).  
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Figure 17 
RAD51 filament-dissociation assay. (A) The reaction scheme adapted from (169). See text 
for explanations. PK, proteinase K; rel, relaxed; sc, supercoiled; TopoI, topoisomerase I. (B) 
Wild-type RAD51 does not form a stable filament on ssDNA in the presence of ATP. The 
RAD51 presynaptic filament was assembled by a 6-min incubation of 1.5 μM RAD51 with 9 
μM circular ssDNA (total nt) in buffer R supplemented with BSA and 2 mM ATP/ATP-
regenerating system at 37°C. Where indicated, successively RECQ5 or RECQ5K58R (75 and 
150 nM) and 7 μM topologically relaxed dsDNA (total bp) together with 4-5 U wheat germ 
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topoisomerase I (TopoI) were added, followed by a 6- and 8-min incubation step, 
respectively. The reaction products were deproteinized with proteinase K, analyzed by 
agarose gel electrophoresis and visualized by ethidium bromide staining. (C) RAD51K133R 
forms stable presynaptic filaments in the presence of ATP. RAD51K133R filament-
dissociation assay was carried out as described above: the filament was pre-formed on 9 μM 
ssDNA (total nt) with 375 nM RAD51K133R, as indicated successively RECQ5 (20, 40, 80, 
160 nM) or RECQ5K58R (160 nM) together with 150 nM RPA and 7 μM relaxed dsDNA (total 
bp) together with 3 U wheat germ topoisomerase I were added. The reaction products were 
analyzed as described above. 
 
 
To have reaction conditions with stable RAD51 filament in the 
presence of ATP co-factor for helicases, we used the ATPase-defective 
mutant of RAD51, RAD51K133R. This mutant has been shown to form stable 
presynaptic filaments in an ATP-bound state and catalyzes strand exchange 
between homologous DNA more efficiently than wild-type RAD51 (63).  
 To displace RAD51K133R from ssDNA, the helicase activity of RECQ5 
was required. Wild-type RECQ5 promoted the formation of supercoiled 
dsDNA product in a concentration-dependent manner in the presence of RPA 
(Fig. 17 C lanes 5-8). In the case of the RECQ5K58R mutant, even at high 
protein concentration and in the presence of RPA, hardly any supercoiled 
dsDNA product was found (lane 13). RPA enhanced the RECQ5-mediated 
release of RAD51K133R from ssDNA (compare lanes 5-8 to 9-12), but could 
not remove Rad51K133R on its own (lane 14). 
 
5.2.3 Analysis of RAD51K133R filament-dissociation activity of RECQ5 
mutants with disrupted RAD51-interaction site 
In order to test if the specific physical interaction between RECQ5 and RAD51 
is required for disruption of stable RAD51K133R filaments by RECQ5, 
RECQ5652-674 and RECQ5F666A mutants were compared with wild-type 
RECQ5 in the RAD51 filament-dissociation assay described above. The 
helicase domain and zinc-binding motif of the mutants are identical to wild-
type RECQ5 suggesting equal translocase activity on ssDNA (Fig. 18 A). The 
activity of the two RECQ5 mutants was therefore estimated from their DNA-
dependent ATPase activity. The formation of inorganic phosphate released by  
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Figure 18 
RAD51K133R filament-dissociation activity of RECQ5 mutants with disrupted RAD51-
interaction site. (A) Scheme of RECQ5 variants used in the analysis. The amino acid stretch 
652-674 is highlighted with a blue box. (B) ATPase activity of RECQ5 variants. ATPase 
activity was determined by colorimetric estimation of the amount of inorganic phosphate (Pi) 
released by ATP hydrolysis. ATPase reactions were carried out at 37°C for 30 min and 
contained 20 nM RECQ5, RECQ5652-674, or RECQ5F666A and 25 μg/ml M13 ssDNA in 
buffer R supplemented with 2 mM ATP and 50 μg/ml BSA. Reactions were stopped by 
addition of EDTA, and the amount of Pi was determined using a malachite green assay 
described in Material and Methods. (C) and (E) RAD51K133R filament-disruption activity of 
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RECQ5 is stimulated via direct RAD51 binding. RAD51K133R filament-dissociation assay 
was carried out as described in Figure 17: the filament was pre-formed on 9 μM ssDNA (total 
nt) with 375 nM RAD51K133R, as indicated successively RECQ5, RECQ5652-674 (C) or 
RECQ5F666A (E) (40, 80, 160 nM) together with 150 nM RPA and 7 μM relaxed dsDNA 
(total bp) together with 3 U wheat germ topoisomerase I were added. (D) and (F) The 
percentage of supercoiled dsDNA product in the RAD51K133R filament-dissociation assay 
was estimated as described in Materials and Methods. The estimation was done for two (D) 
or three (F) assays performed as described above. 
 
 
ATP hydrolysis in the presence of ssDNA was measured and the 
concentrations of the mutant proteins were adjusted to have similar ATPase 
activities as wild-type RECQ5 (Fig. 18 B). Both RECQ5 mutants were capable 
to displace Rad51K133R from ssDNA, but showed a reduction in this activity 
compared with wild-type RECQ5 (RECQ5652-674 Fig. 18 C/D and 
RECQ5F666A Fig. 18 E/F). This result suggests that direct RAD51 binding 
stimulates presynaptic filament disruption by RECQ5. 
 
5.2.4 Analysis of RAD51K133R filament-disruption activity of RECQ5 C-
terminal truncation variants 
Mutational inactivation of the RAD51-interaction site on RECQ5 did not 
completely abolish the ability of RECQ5 to disrupt RAD51K133R filaments. It 
is possible that this residual activity results from action of the N-terminal 
portion of RECQ5 responsible for ssDNA-translocase activity of the enzyme 
[helicase domain and zinc-binding motif (appr. aa 1-470)] or that RECQ5 
contains an additional domain that is involved in the RAD51 filament-
disruption reaction. To address these hypotheses, we tested a series of C-
terminal truncation variants of RECQ5 for the ability to disrupt RAD51K133R 
filaments. In this experiment, we used a C-terminal truncation variant of 
RECQ5 that contained the RAD51-interaction site (RECQ5 1-725), and two 
variants that lack this site of which the former ends at the beginning of the 
RAD51-interaction domain (RECQ5 1-651), whereas the latter is comprised of 
the ssDNA-translocase core only (RECQ5 1-475) (Fig. 19 A). We found that 
RECQ5 1-725 displayed similar RAD51K133R filament-disruption activity as 
wild-type RECQ5 (Fig. 19 C lane 6 and D). The activity of RECQ5 1-651 was 
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Figure 19 
RAD51K133R filament-disruption activity of RECQ5 C-terminal truncation variants. (A) 
Scheme of RECQ5 variants used in the analysis. The location of the amino-acid stretch 652-
725 is highlighted with a blue box. (B) ATPase activity of RECQ5 variants 1-991, 1-725, 1-
651 and 1-475. ATP hydrolysis reactions were carried our as described in Figure 18 B using 
20 nM enzyme, 25 μg/ml ssDNA and 2 mM ATP. (Pi), inorganic phosphate released by ATP 
hydrolysis. (C) Translocase activity of RECQ5 is not sufficient to disrupt efficiently the 
RAD51K133R filament. The dissociation assay was carried out as described in Figure 17: the 
filament was pre-formed on 9 μM ssDNA (total nt) with 375 nM RAD51K133R, as indicated 
successively 160 nM RECQ5 1-991, 1-725, 1-651, or 1-475 together with 150 nM RPA and 7 
μM relaxed dsDNA (total bp) together with 3 U wheat germ topoisomerase I were added. (D) 
The percentage of supercoiled dsDNA product in the RAD51K133R filament-dissociation 
assay was estimated as described in Materials and Methods. The estimation was done for 
three assays performed as described above. 
 
 
found to be in the range observed with RECQ5652-674 and RECQ5F666A, 
confirming the importance of the RAD51-binding domain of RECQ5 for 
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RAD51K133R filament-disruption function (Fig. 19 C lane 7 and D and Fig 
18). In contrast, RECQ5 1-475 could hardly promote the formation of 
supercoild dsDNA product (Fig. 19 C lane 8 and D) although it showed even 
higher ATPase activity relative to wild-type RECQ5, under our experimental 
conditions (Fig. 19 B). Moreover, this variant of RECQ5 was shown to be 
proficient in DNA unwinding (183,184). Collectively, these findings suggest an 
existence of an additional RECQ5 domain located between the zinc-binding 
motif and RAD51-interaction domain that plays an essential role in the 
RECQ5-mediated displacement of RAD51K133R from ssDNA. These findings 
suggest that DNA unwinding and disruption of protein-DNA complexes by 
RECQ5 occur via different mechanisms. 
 
5.2.5 Analysis of RAD51K133R filament-disruption activity of BLM core 
and BLM:RECQ5 chimera  
In a next experiment we wished to better define the contribution of the C-
terminal part of RECQ5 to the RAD51K133R filament-disruption activity. For 
that purpose we used a BLM:RECQ5 chimera composed of the DNA 
translocase core domain of BLM and the C-terminal domain of RECQ5. Like 
RECQ5, BLM can directly bind RAD51. Two RAD51-interaction sites have 
been mapped on BLM, one at the N-terminus (aa 1-212) and one at the C-
terminus (aa 1317-1417) of the protein (236). The full-size BLM has also been 
shown to be capable to disrupt RAD51 filaments in vitro (170). In our 
experiment, we used a translocase-competent core fragment of BLM (229) 
that lacks RAD51-interaction sites (BLM core aa 642-1290) and a BLM-
RECQ5 chimera with the C-terminal part of RECQ5 starting just down-stream 
of the zinc-binding motif (Fig. 20 A). BLM core and BLM:RECQ5 were used in 
concentrations to have similar ATPase activities as wild-type RECQ5 (Fig. 20 
B). In the RAD51K133R filament-dissociation assay, BLM core as well as the 
BLM:RECQ5 chimera showed hardly any activity (Fig. 20 C lanes 7/8 and 
9/10). At present, it is not clear whether BLM:RECQ5 is in general not 
functional due to e.g. improper structural arrangement or whether the C-
terminal part of RECQ5 has no effect on RAD51K133R filament-disruption 
function. The BLM core fragment was reported to exhibit DNA unwinding 
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activity (229) but as in the case of RECQ5 1-475, this appears not to be 
sufficient to displace the RAD51K133R protein from ssDNA.  
 
 
Figure 20 
Analysis of RAD51K133R filament-disruption activity of BLM core and BLM:RECQ5 
chimera. (A) Scheme of proteins used in the analysis: RECQ5, BLM core fragment, and 
BLM:RECQ5 chimera that is composed of the helicase part of BLM (red underlined) and the 
C-terminal part of RECQ5 (blue underlined). The domains indicated are: DExH helicase 
domain; Zn, zinc-binding motif; RQ-CT, RecQ C-terminal domain composed of a zinc-binding 
motif and a winged helix-turn-helix (WH) motif; HRDC, helicase and RNasD C-terminal 
 69
domain; and PIM, PCNA-binding motif. (B) ATPase activity of RECQ5, BLM core, and 
BLM:RECQ5. ATP hydrolysis reactions were carried our as described in Figure 18 B using 20 
nM enzyme, 25 μg/ml ssDNA and 2 mM ATP. (Pi), inorganic phosphate released by ATP 
hydrolysis. (C) Translocase activity of BLM core is not sufficient to disrupt efficiently 
RAD51K133R presynaptic filaments. The displacement assay was carried out as described in 
Figure 17: the filament was pre-formed on 9 μM ssDNA (total nt) with 375 nM RAD51K133R, 
as indicated successively 50 or 100 nM RECQ5, BLM core, or BLM:RECQ5 together with 150 
nM RPA and 7 μM relaxed dsDNA (total bp) together with 3 U wheat germ topoisomerase I 
were added. 
 
 
6 DISCUSSION 
 
6.1 Fork-regression activity of RECQ5 
In the first part of the study, we analyzed the activity of the human RECQ5 
helicase on large M13-based forked DNA structures with a leading-strand gap 
(Fig. 13 A). The model DNA used in our biochemical assays mimics a 
replication fork stalled by a lesion in the leading-strand template. Such 
structures with long ssDNA gaps were observed in vivo upon induction of 
replication-blocking lesions (101,118,119,138). Several pathways have been 
proposed to reactivate blocked replication forks (see chapter 3.4.2). One of 
these pathways includes replication-fork regression. We tested whether 
RECQ5 has the capacity to promote replication-fork regression in vitro.  
RECQ5 was found to process forked DNA substrates with long leading-
strand gaps in a reaction dependent on ATP hydrolysis (Fig. 13 B). Restriction 
enzymes were employed to monitor the formation of fork-regression 
intermediates. In a reaction with the forked substrate containing a 2.1kb 
leading-strand gap, RECQ5 was able to regress the fork junction through a 
region of at least 700bp (Fig. 14 B). In this experiment early regression 
intermediates were detected that form after unwinding of the lagging-strand 
arm and repairing of parental strands (Fig. 14 A). In addition, four-way 
regression-intermediates formed after annealing of the nascent stands were 
monitored by AclI cleavage (Fig. 14 C). The AclI-dependent release of a 
characteristic regressed arm fragment was found when RECQ5 was 
incubated with the forked substrate containing a 0.2kb leading-strand gap 
(Fig. 14 D). In contrast, RECQ5-promoted four-way intermediates were not 
detected by RusA cleavage (Fig. 15 E). 
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In our fork-regression experiments, we compared the activity of 
RECQ5 with that of the E. coli RecG helicase. RecG has been established to 
promote extensive fork regression of the substrate containing a 2.1kb leading-
strand gap (111). Although RecG appeared to act in a non-processive 
manner, the catalyzed regression reaction was unidirectional and fast, 
proceeding at a rate of at least 240bp/s (111). Under our reaction conditions, 
we could observe formation of the linear fork-regression end-products with 
RecG (Fig. 13 B lanes 6 and 13). With RECQ5 we could not detect clearly 
these products (Fig. 13 lanes 2 and 9), indicating that RECQ5 may not 
promote the regression reaction efficiently and/or unidirectionally. Like other 
RecQ members, RECQ5 is thought to be a helicase with low processivity; 
frequent dissociation and rebinding during the unwinding process is expected. 
Helicase reloading and, consequently, branch migration of HJs could 
therefore take place in direction to regress fork further or to restore it. 
On synthetic forked DNA structures, RECQ5 was demonstrated to 
have a preference for unwinding of the lagging-strand arm (131). In an assay 
with synthetic forked DNA structure with non-complementary arms lacking a 
leading strand, RECQ5 was shown to actively unwind the lagging-strand arm 
in a reaction stimulated by RPA (131). In agreement with these results, on 
M13-based fork structure with a 2.1kb leading-strand gap, RECQ5 appeared 
to unwind the lagging-strand arm (Fig. 14 A and B). Detection of the 
characteristic linear duplex fragments after restriction-enzyme cleavage 
indicated that the fork junction had regressed. RPA, expected to bind to the 
ssDNA of the leading-strand gap, slightly stimulated this reaction and did not 
interfere with pairing of the parental strands (Fig. 14 D (ii)). As mentioned 
above, RecQ helicases alone have a low processivity and cannot usually 
unwind more than 40-100bp of standard B-form DNA duplex. Interestingly, the 
BglII-dependent release of a 1.9kb duplex fragment indicated that RECQ5 
without RPA could promote unwinding of more than 700bp of the lagging-
strand arm (Fig. 14 B lane 13). Of course, pairing of parental strands at the 
fork junction could favor the RECQ5-promoted unwinding process by limiting 
re-annealing of the displaced lagging strand. However, the possibility that 
RECQ5 coordinates unwinding of the lagging strand and annealing of parental 
strands cannot be excluded. RecQ helicases are known to prefer complex 
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DNA structures as their substrates (175) and possess intrinsic a ssDNA 
annealing function (184,188-192). Biochemical studies suggested that RecQ 
helicases catalyze rather a strand-exchange reaction than a simple unwinding 
process. It was found for both, BLM and WRN that unwinding of synthetic 
duplex DNA could be enhanced by adding of a DNA oligomer complementary 
to one strand of the DNA substrate (274). In addition, unwinding activity of 
RECQ4 was only seen in the presence of excess complementary ssDNA 
(192). The unique C-terminal domain of RECQ5 has been demonstrated to 
possess DNA strand-annealing activity (184). For RECQ5, a potential way to 
process a forked structure could include annealing of the parental strands 
mediated by the C-terminal domain and unwinding of the lagging strand 
mediated by the N-terminal helicase domain. This hypothesis could be tested 
by using a C-terminal deletion mutant of RECQ5 lacking the annealing 
function. 
Regression of the fork junction beyond the leading-strand gap is 
expected to result in a HJ-like DNA structure by annealing of the liberated 
nascent strands. By AcII and RusA cleavage, we tried to monitor the 
formation of these four-way DNA intermediates. We could detect the AclI-
dependent release of a characteristic regressed arm fragment in reactions 
with RECQ5 (Fig. 14 C and D). In contrast, we were not able to see RECQ5-
promoted RusA fragments (Fig. 15 E). We excluded the possibility that HJ 
cleavage by RusA was significantly hindered in the presence of RECQ5 (Fig. 
15 C). This result challenged the finding that regressed arm fragments 
observed by AclI restriction analysis are formed by RECQ5-promoted fork 
regression. Another source of AclI-dependent fragments, we can think of, is 
direct strand breakage at the fork junction of the substrate. Since we did 
observe fork processing only in reactions with RECQ5 and ATP, this 
breakage would depend on mechanical stress caused by the helicase action 
of RECQ5. Direct visualization of fork-regression intermediates by electron 
microscopy would clarify this issue.  
In summary, RECQ5 processes forked DNA structure in an ATP-
dependent manner and unwinds the lagging-strand arm of the substrate with 
a long leading-strand gap. However, it is not clear if RECQ5 can convert the 
fork structure into a HJ-like intermediate. Other eukaryotic proteins with more 
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robust fork-regression activities are described in literature. The fork-
regression activity of BLM was analyzed on a plasmid-based forked structure 
with a 14nt leading-strand gap (129). By restriction-enzymes digestion, BLM-
promoted regressed arm fragments of more than 250bp in length were 
detected. Interestingly, bacterial RecQ, that is known to unwind the lagging 
strand at replication forks (196), did not shown fork-regression activity on that 
plasmid-based substrate (129). The FA protein, FANCM, has been shown to 
promote extensive fork regression of a plasmid-based fork structure with a 
short lagging-strand gap (128). HJ-like regression intermediates were 
detected both by restriction digest of the regressed arm and by direct 
cleavage of the junction by the HJ-specific endonuclease RuvC (128). 
Furthermore, the yeast Rad5, a member of the SWI/SNF family of ATPases, 
was shown to be able to regress plasmid-based fork structures (135). In 
experiments with synthetic forked molecules, Rad5 only unwound substrates 
with homologous arms. Concertedly unwinding and annealing of nascent and 
parental strands was observed without exposing ssDNA intermediates (135). 
In addition, there is in vivo evidence that yeast Rad5 is involved in a transient 
template switching mechanism for error-free damage-bypass following PCNA 
polyubiquitination (132). The biochemical properties of Rad5 suggest that it 
could directly convert blocked replication forks into HJ-like structures (135). A 
recently published study has suggested that the Rad6-Rad18-Rad5 error-free 
pathway operates under chronic low-dose UV light exposure in proliferating 
yeast cells and allows replication across the damaged template without DNA 
checkpoint activation (133). If such a pathway is operable in higher 
eukaryotes is not yet clear. However, in humans two Rad5 orthologs were 
identified, SHPRH and HLTF (136,137). Like yeast Rad5, SHPRH and HLTF 
contain SWI2/SNF2 subdomains and are involved in polyubiquitination of 
PCNA (136,137). If SHPRH and/or HLTF have the biochemical potential to 
regress a replication fork is not known.   
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6.2 Mechanism of RECQ5-mediated disruption of RAD51 
nucleoprotein filaments 
RECQ5 interacts physically with RAD51 and is suggested to prevent 
inappropriate HR events via RAD51 presynaptic filament disruption (169). In 
the second study, we analyzed the mechanism of RECQ5-mediated 
displacement of RAD51 from ssDNA using a topoisomerase-linked Rad51-
trap assay. In particular, we tested whether physical interaction between 
RECQ5 and RAD51 is required for this activity of RECQ5. 
We identified a single RAD51-interaction domain of RECQ5 that is 
located between aa 654-725 (Fig. 16 A-C). RAD51-RECQ5 complex 
formation in vitro and in vivo could be prevented either by deletion of aa 652-
674 of RECQ5 or by changing phenylalanine 666 of RECQ5 to alanine (Fig. 
16 C-E). RECQ5652-674 and RECQ5F666A were tested for their ability to 
disrupt stable RAD51 filaments formed on ssDNA by an ATPase-defective 
mutant of RAD51, RAD51K133R. Both RECQ5 mutants were still capable to 
displace RAD51K133R from ssDNA, but showed a reduction in this activity 
compared with wild-type RECQ5 (Fig. 18 C-F). This result suggests that direct 
RAD51 binding stimulates presynaptic filament disruption by RECQ5. In 
agreement with this assumption, we found that the C-terminal truncation 
variants of RECQ5, RECQ5 1-725 that physically interacts with RAD51 (Fig. 
16 B lane 9), displayed a similar RAD51K133R filament-disruption activity as 
wild-type RECQ5 (Fig. 19 C/D). The variant RECQ5 1-651, that failed to 
interact with RAD51 (Fig. 16 B lane 8), had a RAD51K133R filament-
disruption activity in a range of those observed with RECQ5652-674 and 
RECQ5F666A (Fig. 18/19). In contrast, the variant RECQ5 1-475 that was 
shown to be proficient in DNA unwinding (183,184) could hardly promote 
RAD51K133R filament disruption (Fig. 19 C/D). This finding suggests the 
involvement of an additional RECQ5 domain located between the zinc-binding 
motif and the RAD51-interaction domain in RECQ5-mediated displacement of 
RAD51K133R from ssDNA. 
Using a BLM:RECQ5 chimera, we tested the hypothesis that the C-
terminal part of RECQ5, starting downstream of the zinc-binding motif, 
confers the helicase/translocase domain of RECQ5 the ability  to disrupt 
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RAD51K133R filaments. However, we found that, like the translocase core of 
BLM, the BLM:RECQ5 chimera was not capable of displacing RAD51K133R 
from ssDNA although it was proficient in ATP hydrolysis in the presence of 
ssDNA, a measure of DNA translocase activity (Fig. 20). This finding suggests 
that the DNA translocase domain of RECQ5 possesses some other unique 
features that are required for its RAD51K133R filament disruption activity. 
Several helicases/translocases have been reported to remove proteins 
from ssDNA. It is not clear whether this activity is specific for a target DNA-
binding protein or it is rather a side action that results from unidirectional 
translocation of these enzymes on ssDNA. Our result suggests that direct 
protein-protein interaction contributes to RECQ5-mediated RAD51K133R 
displacement from ssDNA but is not essential for it. RECQ5 variants with 
disrupted RAD51-interaction domain are still proficient in RAD51K133R 
filament disruption. The finding that the translocase/helicase competent 
RECQ5 1-475 fragment had lost RAD51K133R filament-disruption function, 
suggest a mechanistic difference between DNA unwinding and RAD51 
filament disruption by RECQ5.  
For the bacterial UvrD helicase, different mechanisms for DNA 
unwinding and protein displacement from ssDNA were proposed (153). The 
wrench-and-inchworm mechanism predicts that UvrD interacts directly with 
the duplex region of DNA during unwinding. UvrD proteins with mutations in 
dsDNA-binding motif or mutations that changes structural arrangement of the 
subdomains were found to have still robust DNA unwinding activity but had 
lost dsDNA-binding ability (153). The authors therefore suggested a second 
mode of action in which the protein stays in an open conformation during 
translocation along ssDNA and displaces the partner strand or bound protein 
like a wire-stripper. UvrD was reported to dismantle filaments of RecA as well 
as filaments of Rad51 (161). Recombinase-filament disruption across the 
species was also described for the S. cerevisiae Srs2 helicase. Srs2 interacts 
physically with Rad51 and can disrupt presynaptic filaments formed by Rad51 
and RecA (165,166). It would be interesting to test if RECQ5 has also a 
general protein-displacement activity for nucleoprotein filament formed with 
the RecA/Rad51 family of recombinases. The RecA filament-disruption 
activity of UvrD and Srs2 was tested in vitro by monitoring RecA-promoted 
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DNA strand exchange. In such an assay, inhibition of RecA-promoted strand 
transfer by wild-type RECQ5 or RECQ5 variants could give further insight into 
the general domain requirement for filament-disruption function of RECQ5. 
In yeast, Srs2 is thought to act as an anti-recombinase in vivo by 
disrupting Rad51 presynaptic filaments (165,166). In higher eukaryotes, 
regulation of HR at an early step by antagonizing RAD51 filament formation is 
expected to take place as well. However, an apparent ortholog of the related 
Srs2/UvrD helicases has not been identified. In humans, several potential 
candidates that could act in a similar way to yeast Srs2 are suggested. These 
include FBH1 (167), RTEL1 (168), BLM (170) and RECQ5 (169) (see chapter 
3.5.3). In biochemical experiments, both BLM and RECQ5 have recently been 
shown to be able to displace RAD51 from ssDNA (169,170). Both helicases 
have a role in suppressing mitotic recombination as revealed by the finding 
that their deficiency causes an increase in SCE frequency. The observation 
that the rate of SCEs in the recq5 blm double-knockout mouse ES cells and 
chicken DT40 cells is significantly higher than that in either single mutant 
suggests that RECQ5 and BLM operate in different pathways to suppress 
mitotic recombination (266,267). A likely mechanism how BLM can suppress 
SCEs is by processing late HR intermediates. In vitro, BLM in complex with 
TOPOIII has been shown to resolve DHJs exclusively into non-crossover 
products (52). Although RECQ5 has been shown to coimmuno-precipitate 
with TOPOIII (265), it was not capable in conjuction with TOPOIII of 
catalyzing DHJ dissolution (187). Catalysis of the DHJ dissolution reaction 
seems highly specific for BLM (187). From biochemical experiments, BLM and 
RECQ5 are suggested to negative regulate the initial step of HR by disrupting 
the RAD51 presynaptic filament (169,170). Even though there are 
experimental differences in these studies the RAD51 filament-disruption 
function of BLM and RECQ5 could be diverse. In the presence of RPA and in 
a reaction dependent on ATP hydrolysis, RECQ5 can disrupt RAD51K133R 
filaments [(169) and our data], a stable and catalytically active form of 
presynaptic filaments (63). In contrast, BLM appears only capable of 
disrupting RAD51 filaments in inactive, ADP bound state (170). In a D-loop 
assay, BLM could inhibit RAD51-promoted strand invasion only when added 
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to the presynaptic filaments prior to their activation by Ca2+ ions (170). 
Interestingly, BLM inhibited under these conditions specifically strand 
exchange by the human RAD51, but not by the yeast Rad51 or human 
meiotic recombinase DMC1 (170). Under our condition with the stable 
RAD51K133R filament, we only tested the BLM core fragment (aa 642-1290) 
that lacks RAD51-interaction domains that have been mapped at the N-
terminus (aa 1-212) and at the C-terminus (aa 1317-1417) of the protein 
(236). This translocase competent BLM core fragment (229) was not able to 
displace RAD51K133R from ssDNA (Fig. 20). It is not yet clear if this fragment 
is not sufficient for the RAD51 displacement function, similar to RECQ5 1-475 
or if BLM is not capable of disrupting RAD51K133R filaments. The full-size 
BLM should therefore be tested for the ability to disrupt RAD51K133R 
filament to clarify this issue.  
 
6.3 Conclusions and perspectives 
RecQ DNA helicases display preference for complex DNA structures and are 
involved in cellular process where such DNA structures arise that is DNA 
replication and recombination. Defects in these enzymes are associated with 
hyper-recombination phenotype and genome instability. The human RECQ5 
helicase associates with the replication machinery and accumulates at sites of 
stalled replication forks and DSBs (131,268). Moreover, recent studies 
suggested that RECQ5 regulates HR through disruption of RAD51 
presynaptic filaments (169).  
In the first study, we analyzed the activity of RECQ5 on M13-based 
forked DNA structures with a leading-strand gap. RECQ5 showed ATP-
dependent activity on such structures, could unwind the lagging-strand arm, 
but was not efficient in converting fork structures into four-way DNA 
structures. Our biochemical result and fork-regression activities described in 
literature of other helicases/translocases, suggest that RECQ5 might not be 
the ideal enzyme to promote reactivation of stalled replication forks via a 
template-switching mechanism.  
In the second study, we analyzed the mechanism underlying disruption 
of RAD51 filaments by RECQ5. We found that direct interaction between 
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RECQ5 and RAD51 enhances filament-disruption activity of RECQ5, but it is 
not essential for it. In addition, we found that the helicase/translocase core of 
RECQ5 is not sufficient to displace RAD51 from ssDNA suggesting a 
mechanistic difference between DNA unwinding and protein-DNA complex 
disruption by RECQ5.  
There are still many open questions concerning the role of RECQ5 as 
an anti-recombinase. Firstly, it is not clear whether RECQ5 has a general 
protein-displacement activity for nucleoprotein filaments formed with the 
RecA/Rad51 family of recombinases, similar to yeast Srs2 and bacterial UvrD. 
Secondly, the redundancy between the RAD51 filament-disruption function of 
BLM and RECQ5 in vitro is not yet established. Comparing the activity of BLM 
and RECQ5 under identical reaction condition could show if there is a 
difference in disruption function concerning the stability and ATP-state of 
RAD51 filaments. Finally, the importance of the direct RECQ5-RAD51 
interaction for anti-recombinase function of RECQ5 in vivo is not clear and will 
be analyzed in collaboration with Prof. Jeremy M. Stark. The repair by HR of a 
defined DSB in a reporter constructs will be analyzed in human cells over-
expressing wild-type RECQ5 or RECQ5 mutants with disrupted RAD51-
interaction domain. 
We believe that apart from acting as an anti-recombinase in the 
classical DSBR pathway, RECQ5 has a potential to prevent stalled replication 
forks with ssDNA gaps from inappropriate recombination by displacing bound 
RAD51. Studies of the effect of RECQ5 deficiency on the rate of replication-
fork progression will address this issue. 
 
 
7 MATERIAL AND METHODS 
 
Abbreviations 
RT  room temperature 
 
ATP  adenosine triphosphate 
ATPS adenosine 5’-O-(3-thio)triphosphate 
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EDTA  ethylenediamine tetraacetic acid 
EtBr  ethidium bromide 
EtOH  ethanol 
CTAB  cetyl trimethylammonium bromide (cationic tenside) 
DTT  dithiothreitol 
IPTG   isopropyl-1-thio--D-galactopyranoside 
PEG   polyethylenglycol 
PMSF  phenylmethylsulfonylfluoride 
SDS-PAGE sodium dodecylsulfate polyacrylamide gel electrophoresis 
 
Preparation of bacteriophage M13 DNA 
E. coli strain JM109 (containing the F episome and an amber suppressor 
mutation) was infected with M13mp8.32 (116) and grown in 2X YT medium 
overnight at 37°C. M13mp8.32 ssDNA was isolated from the supernatant of 1 
l culture. The supernatant was heated to 70°C for 30 min, cooled down to RT 
and cleared by centrifugation (10 000 x g for 15 min). The phage particles 
were precipitated with 250 ml of 20% (w/v) PEG8000/2.5 M NaCl overnight at 
4°C. The phage precipitate was collected by centrifugation (10 000 x g for 30 
min at 4°C) and resuspended in a small volume of PBS (pH 7.4) (about 15 
ml). The phage particles were allowed to dissolve by shaking moderately for 
1-2 h at RT and cleared from residual bacterial cells by centrifugation (24 000 
x g for 15 min at 4°C). To remove contaminating E. coli chromosomal DNA, 
the supernatant was supplemented with 50-60 U of DNaseI and 15 mM MgCl2 
and incubated for 2 h at 37°C. The DNaseI reaction was stopped by adding 
EDTA to a final concentration of 60 mM and heating to 80°C for 20 min. 
Thereafter, the capsid proteins which protect the M13mp8.32 ssDNA were 
digested with proteinase K (0.1 mg/ml, 37°C overnight). The free ssDNA was 
precipitated by adding 0.1 volume of 5% (w/v) CTAB/0.5M NaCl, kept for 10 
min at RT and centrifuged (10 000 x g for 20 min). The pellet was dissolved in 
5 ml 1.2 M NaCl and ssDNA was precipitated by adding 12.5 ml cold absolute 
EtOH. After incubation at -20°C for at least 1h, the suspension was 
centrifuged (23 000 x g for 30 min at 4°C), the pellet rinsed with 5 ml 70% RT 
EtOH and centrifuged again (23 000 x g for 10 min at 4°C). The DNA pellet 
was then air-dried and dissolved in a small volume (about 1 ml) of 10 mM 
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Tris-HCl (pH 8.0). Concentration of ssDNA was measured by absorbance at 
260 nm using a conversion factor of 36 μg/ml (116). The yield was about 1 mg 
of M13mp8.32 ssDNA for 1 l of starting culture. 
 The supercoiled M13mp8.32 dsDNA was purified from infected JM109 
cells using the QIAGEN Plasmid Maxi Kit. Briefly, cell pellet from 1 l 2X YT 
culture was washed with STE buffer [10 mM Tris-HCl (pH 8), 0.1 M NaCl, 1 
mM EDTA] and DNA was prepared according to the manufacturer’s protocol. 
Double amounts of the buffers P1, P2 and P3 were used. The obtained DNA 
was treated with 100 U of Plasmid-Safe ATP-Dependent DNase (Epicentre) in 
the manufacturer’s reaction buffer (Epicentre) supplemented with 1 mM ATP 
overnight at 37°C. The enzyme was heat inactivated (70°C for 30 min) and 
DNA precipitated by adding 2.5 volumes of cold absolute EtOH and 0.1 
volume of 3 M Na-acetate (pH 5.2) followed by incubation at -20°C overnight. 
The precipitated DNA was pelleted using an Eppendorf microcentrifuge (14 
000 rpm for 20 min at 4°C). The pellet was washed with 70% RT EtOH (14 
000 rpm for 10 min at 4°C), air-dried and dissolved in 10 mM Tris-HCl (pH 8). 
The yield of DNA was about 450 μg for 1 l culture. DNA concentration was 
determined by measuring absorbance at 260 nm using a conversion factor of 
50 μg/ml.  
 
Preparation of DNA substrate for fork-regression assay 
DNA substrates that mimic stalled replication forks with a defined ssDNA gap 
on the leading strand (2.1kb, 0.2kb, 0.06kb or no gap) were assembled from a 
circular gapped duplex (gd) DNA and a homologous linear dsDNA arm ligated 
to a synthetic linker (116) (Fig. 12). Gd DNA was produced by a RecA-
mediated strand-exchange reaction between circular M13mp8.32 ssDNA and 
a defined M13mp8.32 dsDNA fragment (5.2kb-[BsrGI-EcoRI], 7.1kb-[BglI-
EcoRI], 7.3kb-[HindIII-EcoRI], or 7.3kb-[AccI-EcoRI]) (Fig. 21). The dsDNA 
fragments were purified from agarose gel using QIAquick Gel Extraction Kit 
(Qiagen). In more detail, the strand-exchange reaction was carried out with 
6.7 μM RecA protein, 2 μM E. coli ssDNA binding protein (SSB), 20 μM 
circular ssDNA (total nt) and linear dsDNA fragment in excess (ssDNA and 
dsDNA molecules in a molar ratio of 1:1.3). The RecA-reaction buffer 
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contained 25 mM Tris-acetate (pH 7), 10 mM Mg-acetate, 3 mM potassium 
glutamate, 1 mM DTT, 5 % (v/v) glycerol and was supplemented with 3 mM 
ATP, 50 μg/ml BSA and an ATP regenerating system [10 U/ml creatine 
phosphokinase (SIGMA, C3755) and 12 mM phosphocreatine (SIGMA, 
P7936) (275). A large-scale gd DNA preparation was performed in a volume 
of 500-800 μl at 37°C. The RecA filament was preformed on ssDNA for 10 
min and the strand-exchange reaction started by adding ATP, SSB and the 
dsDNA fragment. After incubation for 2 h, RecA was heat-inactivated (80°C 
for 20 min) and DNA deproteinized with trypsin (100 μg/ml). 1 M Tris-HCl (pH 
8) was added to the reaction to a final concentration of 50 mM and the digest 
allowed to proceed for 2 h at 37°C. After trypsin-heat inactivation (70°C for 15 
min), deproteinized DNA species were separated by 1% agarose gel 
electrophoresis at 40 V for 14-16 h in 0.5 x TBE buffer (45 mM Tris base, 45 
mM Borate, 1 mM EDTA) at 4°C and gd DNA was extracted from gel by 
electroelution (111). Briefly, a small part of the gel was stained with EtBr to 
visualize the position of the gd DNA band. The band of gd DNA was cut out 
from the unstained part of the gel and the gd DNA extracted from the gel slice 
by electroelution in dialysis bag (Spectra/Por, molecular weight cutoff: 3.500). 
Electroelution was carried out in a standard agarose electrophoresis 
apparatus (GE Healthcare Minnie gel unit 80-6052-45) for 5 h at 100 V in 0.5 
x TBE buffer at 4°C. The polarity of the current was reversed for 1 min before 
gd DNA was recovered from dialysis bag. The gd DNA, typically in a volume 
of 2-3 ml was concentrated using Centricon 30 (Amicon) and the buffer was 
exchanged for 10 mM Tris-HCl (pH 8). Concentration of purified gd DNA was 
estimated from agarose gel. 
 The arm fragment of the branched DNA substrate was prepared by 
digestion of supercoiled M13mp8.32 dsDNA with SapI and SmaI enzymes 
followed by purification of the 7.3kb-[SapI-SmaI] fragment by gel 
electrophoresis and extraction with QIAquick Gel Extraction Kit (Qiagen).  
The linker DNA was prepared by annealing two synthetic oligonucleotides: the 
5’-phosphorylated oligo 1MP 5’-
CACCGAAGAGCGCACGGTGCCGCGCGCGGCGCCTCGACGGATCCCCG
GG and the oligo 2M 5’- GGCGCCGCGCGCGGCACCGTGCGCTCTTCG 
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(Microsynth). The nucleotides in bold are mismatches with respect to 
M13mp8.32 sequence. One end of the linker (3-nt 5’-overhang) is 
complementary to the SapI cleavage site of the 7.3kb-[SapI-SmaI] fragment 
and the other end of the linker (16-nt 3’-overhang) is complementary to the gd 
DNA downstream of the EcoRI site. First, the linker was ligated with the 
7.3kb-[SapI-SmaI] fragment using T4 DNA ligase. Typically, about 15 μg of  
 
 
Figure 21.  
Restriction map of M13mp3.82 DNA. Unique sites used are indicated by blue arrows. The 
used AclI double site is indicated in blue. 
 
 
7.3kb-[SapI-SmaI] fragment and linker DNA in about 20-fold molar excess 
were incubated with 40 U T4 DNA ligase (New England Biolabs) in a volume 
of 240 μl of T4 DNA ligase buffer (New England Biolabs) for 16 h in a PCR 
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machine running a cycling program of endless change between 10°C for 30 
sec and 30°C for 30 sec. The ligation product was purified by agarose gel 
electrophoresis, extracted with QIAquick Gel Extraction Kit (Qiagen) and 
ligated with the purified gd DNA using Taq DNA ligase (New England 
Biolabs). This reaction was carried out with gd DNA and linker-[SapI-SmaI] 
fragment in about 1:10 ratio, with 100 U of Taq DNA ligase in a volume of 200 
μl of Taq reaction buffer (New England Biolabs) overnight at 45°C. The 
branched ligation product was either first linearized by MscI or directly purified 
by 0.7% agarose gel electrophoresis followed by electroelution as described 
above. Concentration of purified branched DNA molecules was estimated 
from agarose gel (see e.g. Fig. 12 C lanes 13-19). 
 
Preparation of Holliday junction-containing DNA  
We produced Holliday junction (HJ)-containing DNA in vivo using the E. coli 
strain RM40/pSD115 (273). In this strain expression of the XerC recombinase 
is under control of the lac promoter. RM40 is transformed with the plasmid 
pSD115 (4.95kb) harboring two copies of the cer recombination sites in direct 
orientation. 1 l RM40/pSD115 culture was grown at 37°C in LB medium 
containing 150 μg/ml ampicillin, 50 μg/ml diaminopimelic acid, and 1% 
glucose to maintain repression of the lac promoter. Expression of XerC was 
induced by adding 2 mM IPTG at an OD600 of 0.5. Under this condition cer 
sites of pSD115 are recombined intramolecularly, resulting in a HJ-containing 
plasmid. RM40 culture was allowed to grow under induced conditions for 1h at 
37°C. Cells were then harvested and plasmid DNA isolated with the QIAGEN 
Plasmid Maxi Kit. The isolated DNA consisted of a mixture of pSD115 DNA in 
non-recombined, recombined and resolved conformations (Fig. 15 A). HJ-
containing pSD115 plasmid, resembling a figure 8 structure, was converted 
into an -structure by EcoRI cleavage and the -structure was purified by 
0.9% agarose gel electrophoresis (30 V for 16 h in 0.5 x TBE buffer at 4°C) 
and extracted from the gel by electroelution (described above). 
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Proteins used in the fork-regression assay 
RECQ5 and RECQ5K58R proteins were produced as C-terminal fusions with 
self-cleaving Mxe-CBD affinity tag in bacteria and purified as previously 
described (184,276). 
 RecG purification was adapted from published protocol (277). The 
detection method used to follow RecG protein during purification was SDS-
PAGE, using the known molecular weight of RecG (76 kDa). RecG protein 
was produced in E. coli BL21(DE3) transformed with the plasmid pAF201 
harboring RecG gene under control of IPTG-inducible promoter. 2-4 l of cells 
were grown in LB medium containing 150 μg/ml ampicillin at 37°C. RecG 
expression was induced by adding 1 mM IPTG at an OD600 of 0.5. Cells were 
either grown for additional 6 h at 37°C or for 16 h at 18°C. Overall RecG 
expression was higher in cells grown at 37°C, but solubility of the protein was 
better in cells grown at 18°C. Cells were harvested by centrifugation, washed 
with STE buffer and dissolved in about 80 ml lysis buffer [20 mM Tris-HCl (pH 
8.5), 400 mM NaCl, 1 mM DTT, 1 mM EDTA, 0.1 % Triton X-100, 10% 
glycerol]. Cell suspensions were frozen in liquid nitrogen, and stored at -80°C. 
After thawing cell suspensions, 0.5 mM of the protease inhibitor PMSF was 
added and cells were disrupted using a French press. Cell lysate was clarified 
by centrifugation (40 000 x g for 1h at 4°C). Nucleic acid in the supernatant 
was removed by the addition of polyethylenimine up to 0.5 %, incubation for 
30 min at 4°C and centrifugation (40 000 x g for 30 min at 4°C). From the 
supernatant, proteins including RecG were precipitated with 70% saturation of 
ammonium sulfate (stirring on ice for 45 min). After centrifugation (40 000 x g 
for 30 min at 4°C), the protein pellet was resuspended in about 30 ml of R-
buffer [20 mM Tris-HCl (pH 7.5), 1 mM DTT, 10 % glycerol] and dialyzed 
against 4 l of R-buffer/500 mM NaCl (Spectra/Por dialysis membrane, 
molecular weight cutoff: 3.500). Precipitates were removed from the dialyzed 
solution by centrifugation (40 000 x g for 30 min at 4°C), and 4 volumes of R-
buffer were added. The solution was then applied to a DEAE-Sepharose FF 
column equilibrated with R-buffer/100 mM NaCl. The flow-through was loaded 
directly onto a SP-Sepharose column equilibrated with the same buffer and 
eluted with a linear gradient of NaCl (0.1-1.0 M) in R-buffer. Fractions 
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containing RecG, which were eluted around 500 mM NaCl, were pooled, 
diluted with R-buffer to approximately 200 mM NaCl and applied to a HiTrap 
heparin column equilibrated with R-buffer/200 mM NaCl. Proteins were eluted 
from the column with a linear gradient of NaCl (0.2-1.0 M) in R-buffer. Peak 
fractions containing about 95% pure RecG protein were aliquoted, frozen in 
liquid nitrogen, and stored at -80°C. Protein concentration was measured by 
Bradford method using BSA as a standard. 
 RusA protein was purified as described (278) with some modifications 
from 1 l culture of E. coli BL21pLysS harboring RusA expression vector 
pET19-b. Cells were grown in LB medium containing 150 μg/ml ampicillin and 
25 μg/ml chloramphenicol at 37°C to an OD660 of 0.6 and protein synthesis 
was induced by adding 1 mM IPTG, followed by an 2 h incubtion at 37°C. 
Cells were harvested by centrifugation, washed with STE buffer, resuspended 
in 25 ml of 20 mM sodium phosphate (pH 7) supplemented with 0.5 mM 
PMSF and disrupted by sonication. Cell lysate was clarified by centrifugation 
(40 000 x g for 45 min at 4°C). The supernatant was subjected to fractional 
protein precipitation. An initial protein precipitation was induced with 
ammonium sulfate at 55 % saturation (stirring on ice for 1 h 20 min). After 
centrifugation (40 000 x g for 45 min at 4°C), further ammonium sulfate was 
added to the supernatant to a final concentration of 85 % saturation (stirring 
on ice for 1 h 20 min), following centrifugation as above. The protein pellet 
was then resuspended in 30 ml of HS buffer [20 mM sodium phosphate (pH 
7), 1 mM DTT] and the solution applied to HiTrap SP column equilibrated with 
HS buffer. Proteins were eluted with a linear gradient of NaCl (0-2 M) in HS 
buffer. Fractions containing RusA in high concentration and purity of more 
than 95% were identified by SDS-PAGE, pooled (end volume 5 ml), 
supplemented with 0.1 mM PMSF and dialysed overnight against 0.5 l of 
storage buffer [50 mM Tris-HCl (pH 8), 200 mM NaCl, 1 mM DTT, 50 % 
glycerol] and stored at -20°C. Protein concentration was measured by 
Bradford method using BSA as a standard. 
 Human RPA was purified as described (279). Restriction enzymes and 
E. coli RecA protein were purchased from New England Biolabs. E. coli 
single-stranded DNA Binding Protein (SSB) was purchased from Promega. 
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Fork-regression assay 
Reactions were carried out at 37°C in 1 x NEB4 buffer (New England 
BioLabs) supplemented with 50 g/ml BSA in a volume of 15 μl. About 10 pM 
DNA substrate was incubated with indicated concentrations of RECQ5, 
RECQ5K58R or RecG in the presence of 2 mM ATP or ATPS as indicated 
for 30-60 min. Where included, 20 or 40 nM RPA was pre-incubated with 
substrate DNA for 2 min before addition of the helicase. After the reaction, 
fork-regression products were directly deproteinized or further processed by 
restriction endonuculease or RusA cleavage as described below. To 
deproteinize and stop the reactions, samples were incubated for 20 min at 
37°C with 1 % SDS, 12 mM EDTA, and 1 mg/ml proteinase K. The DNA 
products were then separated by 0.7% agarose gel electrophoresis, typically 
at 45 V for 4 h in 0.5 x TBE buffer, and transferred to a Zeta-Probe membrane 
(Bio-Rad catalog #162-0196) according to standard protocols for Southern 
blotting. The blots were shortly equilibrated in 2 x SSC buffer (0.3 M NaCl, 30 
mM Na-citrate) and air-dried. Before hybridization, the membrane was soaked 
in 6 x SSC, pre-incubated with hybrisol I (CHEMICON, Cat. No. S4040) for 2 
h at 45°C and further incubated with fresh hybrisol I containing radiolabeled 
probes (described below) overnight at 45°C. Next day, the membrane was 
rinsed with 2 x SSC, washed successively with 2 x SSC/0.1% SDS (at 41°C 
for 15 min), 0.5 x SSC/0.1% SDS (at 41°C for 15 min) and 0.1 x SSC/0.1% 
SDS (at RT for 2 min). DNA products on membrane were detected by 
autoradiography (Phosphor Screen from Molecular Dynamics, Typhoon 9400 
scanner). 
 The probes for Southern blotting were prepared using the Random 
Primed DNA Labeling Kit from Roche (Cat. No. 1 004 760). The labeling 
reaction was performed according to manufacturer’s protocol with [-32P]CTP 
and 50 ng of linear dsDNA fragment as template: M13mp8.32 1.2kb-[MscI-
SapI], M13mp8.32 2.1kb-[EcoRI-BsrGI], or pSD115 0.95kb-[EcoRI-SalI]. 
Probes generated in one reaction lasted for 2-3 hybridizations. 
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RusA cleavage assay 
RusA cleavage assay was carried out in 1 x NEB4 buffer directly after fork-
regression assay described above. Fork-regression reaction-mixtures 
containing about 10 pM DNA substrate were supplemented with 5 nM RusA 
and 100 ng of oligonucleotide f-10-C [5’-
GAGGTCACTCCAGTGAATTCGAGCTCGCAGCCCCTCTAGGTTACATGAC
TGAATGATAGT-3’], that served as a trap for helicases, and incubated for 
additional 30 min at 37°C (end volume 20 μl).  
For pSD115 -structure, RusA cleavage reaction was carried out in 1 x 
NEB4 buffer supplemented with 50 μg/ml BSA for 30 min at 37°C. About 20 
nM DNA was incubated with 10 nM RusA in the presence or absence of 2 mM 
ATP, 9 mM ATPS and 100 ng ssDNA (oligo f-10-C) as indicated (reaction 
volume 15 μl). Where RECQ5 was included, DNA was pre-incubated with 50 
nM RECQ5 and 2 mM ATP for 15 min before addition of RusA.  
DNA products were deproteinized by proteinase K treatment and 
analyzed by agarose gel electrophoresis and Southern blotting as described 
above. 
 
Plasmid constructs and recombinant proteins 
To produce mutant variants of human RECQ5 for purification and for chitin-
binding domain (CBD) pull-down assays, the following plasmid constructs 
were used. All plasmids are derivatives of the bacterial expression vectors 
pTXB1 (New England Biolabs), in which protein of interest is expressed as a 
C-terminal fusion with a self-cleaving Mxe-CBD affinity tag. Plasmid pPG10 
codes for wild-type RECQ5 (amino acids 1-991), pPG17 for RECQ5 1-410, 
pPG19 for RECQ5 1-475, pPG21 for RECQ5 1-561, pPG20 for RECQ5 1-
651, pPG18 for RECQ5 1-725, pPG11 for RECQ5 675-991, pPG16 for 
RECQ5 411-991, and pPG10K58R for RECQ5K58R (131,184).  
In addition, the expression vector for RECQ5 529-725 fragment 
(pTXB1-hRQ5 529-725) was constructed by PCR amplification of the 
corresponding part of RECQ5 cDNA from pPG10 (primers hRQ5-45 and 
hRQ5-21) and the PCR product cloned into pTXB1 via NdeI/SapI sites. The 
internal deletion variant RECQ5640-653 (pPG10640-653) was constructed 
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by PCR amplification of RECQ5 cDNA in two separate PCR reactions. The 
primers used were hRQ5-3 and Del2-1918-1958R for the N-terminal coding 
sequence of RECQ5 and hRQ5-4 and Del2-1918-1958F for the C-terminal 
coding sequence. The PCR products were cleaved with SacI and Acc651 (N-
terminal coding sequence), Acc65I and Bsu36I (C-terminal coding sequence) 
and linked with the pPG10[Bsu36I-SacI] fragment in a three-fragment ligation 
reaction. Thereby two additional codons GGTACC (Acc65I site) were 
introduced between the N- and C- terminal portions of the RECQ5 coding 
sequence. The internal deletion variant RECQ5652-674 (pPG10652-674) 
and RECQ5652-725 (pPG10652-725) were constructed using the same 
strategy but the isoschizomer KpnI was used instead of Acc65I. For 
RECQ5652-674 the primers for the PCR reactions were hRQ5-3 and Del2-
1954-2022R for the N-terminal coding sequence and hRQ5-4 and Del2-1954-
2022F for the C-terminal coding sequence. For RECQ5652-725 the primers 
were hRQ5-3 and Del2-1954-2022R (for N-terminal coding RECQ5 cDNA), 
and hRQ5-4 and Del2-725F (for C-terminal coding RECQ5 cDNA). Another 
three expression vectors for RECQ5515-568 (pPG10515-568), 
RECQ5543-607 (pPG10543-607) and RECQ5571-653 (pPG10571-653) 
variants were constructed using restriction enzymes. The pPG10515-568 
plasmid results from FspI/BsaAI deletion of pPG10. The pPG10543-607 
plasmid results from BamHI/EcoRV deletion of pPG10 where BamHI end was 
filled by Klenow fragment. The pPG10571-653 plasmid results from 
BsaAI/Acc65I deletion of pPG10640-653 where the Acc65I end was filled by 
Klenow fragment. Expression vector for RECQ5-R654A, RECQ5-F659A, 
RECQ5-F666A and RECQ5-E671A mutants were prepared using 
QuickChange Site-Directed Mutagenesis Kit (Stratagene) according to 
manufacturer’s instructions. Wild-type and mutant RECQ5 proteins were 
purified as described previously (131,184). 
 Plasmid construction and protein purification for BLM core fragment 
encompassing amino acid residues 642-1290 were described (229). To 
construct the chimera protein BLM:RECQ5 composed of aa 642-1072 of BLM 
and aa 438-991 of RECQ5, a EagI site was introduced into the BLM encoding 
plasmid pJP73 by site-directed mutagenesis using the primers BLM-42/-43. 
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The EagI-SacII fragment of the resulting plasmid was replaced by the 
pPG10[EagI-SacII] fragment. 
 For ectopic expression of RECQ5, RECQ5652-674 and 
RECQ5F666A in 293T cells, the mammalian expression vector 
pcDNA3.1/HisC (Invitrogen) was used. For wild-type RECQ5, a construct 
named pJP136 was already available in the laboratory. It was constructed by 
cloning RECQ5 cDNA into the multiple cloning site of pcDNA3.1/HisC via 
BamHI/NdeI and EcoRI sites. Expression vector for RECQ5652-674 
(pJP136652-674) was generated by ligation of the pJP136[Bsu36I-BstEII] 
fragment with the pPG10652-674[BstEII-Bsu36I] fragment. The expression 
vector for RECQ5F666A was constructed using the same strategy. 
 Wild-type RAD51 and RAD51K133R used in protein interaction assays 
were purified by Igor Shevelev according to previously published protocol 
(280). The bacterial expression vector for wild-type RAD51 (pFB530) was 
obtained from Dr. Stephen West. The expression vector for RAD51K133R 
(pFB530KR) was generated by site-directed mutagenesis using the primers 
hRAD51KR-T/B. 
 Human RPA and E.coli Topoisomerase I were purified as described 
(279). 
 Wheat germ topoisomerase I (M2851) was purchased from Promega. 
 
Primers 
Name Sequence (5’-3’) 
Restriction 
site 
Del2-1918-
1958F 
GAGTATGGTACCCGGGTGGGAGCTGGTTTCCCC 
 
Acc651 
Del2-1918-
1958R 
CACCCGGGTACCATACTCATTGGGCTCCGGGGG 
 
Acc651 
Del2-1954-
2022F 
CTCAAAGGTACCACGACTCGGATCAGGGAGCAAG Acc651 
Del2-1954-
2022R 
AGTCGTGGTACCTTTGAGCGAGTACACATGGGAG Acc651 
Del2-725F AGTCGTGGTACCCCCTCCCCTGAGAAGAAGGC Acc651 
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hRAD51KR-
B 
GACAGATCTGGGTCCTCCCAGTTCGGAATTC - 
hRAD51KR-
T 
GAATTCCGAACTGGGAGGACCCAGATCTGTC - 
hRQ5-21 AAGGCCGCTCTTCCGCACATCCCCCCATAGTGAGCGCTGCC SapI 
hRQ5-3 GGGAATTCCATATGAGCAGCCACCATACCACCTTTCCTTTT - 
hRQ5-4 AAGGCCGCTCTTCCGCATCTCTGGGGGCCACACAGGCCATGCCAG - 
hRQ5-45 GGGAATTCCATATGGATGAGAACTGTCCCCTGAAA NdeI 
BLM-42 TAATTGCTGTAAAACAAAGGCGGCCGAAACAAGAGATGTGACTGAC EagI 
BLM-43 ATTGGCATTGATATATAAGTCTTCATCCAA - 
 
 
Cell culture and preparation of total cell extracts 
HEK 293T cells were cultivated in Dulbecco modified Eagle’s medium 
(DMEM) (Gibco) supplemented with 5% fetal calf serum (Life Technologies), 
streptomycin (100 U/ml) and penicillin (100 μg/ml). 
For extract preparation, cells at confluency of 90-100% were 
trypsinized, washed twice in PBS, and cell pellets frozen in liquid nitrogen and 
stored at -80°C. All centrifugation steps were done at 900 rpm for 5 min 
(Eppendorf centrifuge 5810R). Extracts were prepared before use. One frozen 
pellet (from a 15 cm dish) was thawed on ice, dissolved in 1 ml of IP buffer 
[50 mM Tris-HCl (pH 8), 120 mM NaCl, 0.5% (v/v) NP-40] supplemented with 
0.3 mM PMSF and a protease inhibitor cocktail (complete EDTA free from 
Roche), incubated for 20-30 min at 4°C, and centrifuged at 14’000 rpm for 20 
min at 4°C (Eppendorf microcentrifuge).  The supernatant was transferred to 
a fresh tube and centrifuged for additional 10 min as above. This clarified 
supernatant was used as total cell extract in CBD pull-down assays. Protein 
concentration was measured by Bradford method using BSA as a standard. 
 
Chitin Binding Domain (CBD) pull-down assay 
RECQ5 protein and its variants were produced as C-terminal fusions with 
CBD tag in E. coli BL21(DE3). Cells were grown at 37°C in LB medium 
containing 150 μg/ml ampicillin and 25 μg/ml chloramphenicol to an OD600 of 
 90
about 0.3, induced by adding 0.2 mM IPTG and incubated overnight at 18°C. 
Cells harvested from a 10-ml culture were resuspended in 1 ml of CH buffer 
[20 mM Tris-HCl (pH 8), 500 mM NaCl, 1 mM EDTA, 0.1% (v/v) Triton X-100] 
supplemented with 0.5 mM PMSF and a protease inhibitor cocktail (complete 
EDTA free from Roche). Cells were disrupted by sonication and extracts 
clarified by centrifugation in a Eppendorf microcentrifuge at 14 000 rpm for 45 
min at 4°C. Typically, 50 μl of the cleared extract were incubated with 25 μl of 
chitin beads (New England Biolabs) in a total volume of 500 μl of CH buffer 
supplemented with 0.2 mM PMSF and protease inhibitor cocktail for 2 h at 
4°C. The beads were then washed once with 1 ml of CH buffer and three 
times with 1 ml of IP buffer [50 mM Tris-HCl (pH 8), 120 mM NaCl, 0.5% (v/v) 
NP-40]. After each wash, beads were collected by centrifugation at 5000 rpm 
for 2 min at 4°C (Eppendorf microcentrifuge). The washed beads were then 
incubated either with total cell extract from 293T cells (600-1000 μg) or with 
recombinant RAD51 protein (20-250 ng) in a volume of 500 μl of IP buffer 
supplemented with PMSF and protease inhibitor cocktail for 2 h at 4°C. The 
beads were again washed three times with IP buffer as above. Proteins were 
eluted from beads by boiling at 95°C for 7 min in 25 μl of 3 x SDS loading 
buffer, separated by 10% SDS-PAGE and analyzed by Western blotting with 
anti-RAD51 antibody. 
 
Nickel pull-down assay 
293T cells were transiently transfected with either the expression vector for 
RECQ5, RECQ5652-674, RECQ5F666A or the corresponding empty vector 
(pCDNA3.1/HisC) using Metafecten reagent (Biontex). To do so, 1 x 106 cells 
were plated in 10 cm dishes one day before transfection. 2 μg of DNA in 100 
μl DMEM were mixed with 7 μl of Metafecten in 100 μl DMEM, incubated at 
RT for 20 min and added to one 10 cm dish containing cells at about 40% 
confluency. Cells were harvested 48-64 h post-transfection. For that purpose, 
dishes were placed on ice, cells washed twice with 8 ml cold PBS and lysed in 
500 μl of extraction buffer [50 mM Tris-HCl (pH 8), 120 mM NaCl, 20 mM 
NaF, 15 mM sodium pyrophosphate, 0.5% (v/v) NP-40] supplemented with 1 
mM benzamidine, 0.2 mM PMSF, 0.5 mM sodium orthovanadate and 
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protease inhibitor cocktail (complete EDTA free from Roche). Cell suspension 
was gently scraped off the dish, snap frozen in liquid nitrogen, thawed and 
centrifuged at 14 000 rpm for 12 min at 4°C (Eppendorf microcentrifuge). The 
clarified supernatant (total protein extract) was used in Nickel (Ni) pull-down 
assay. To immobilize the ectopically expressed (His)6-tagged RECQ5 
variants, 800-1000 μg total protein extract was incubated with 25 μl Ni-NTA-
Agarose beads (Qiagen) in a volume of 500 μl of extraction buffer 
supplemented with protease/phosphatase inhibitors as above and 20 mM 
imidazole for 2h or overnight at 4°C. Where required, 50 μg/ml EtBr was 
included in incubation or extracts were pre-treated with 20 U DNaseI (Roche) 
for 20 min at 25°C in the presence of 6 mM MgCl2 and 1 mM CaCl2. After 
incubation the beads were washed three times with 1 ml of extraction buffer 
supplemented only with PMSF and 20 mM imidazole, beads were collected 
after each washing step by centrifugation at 5000 rpm for 2 min at 4°C 
(Eppendorf microcentrifuge). Proteins were then eluted from nickel beads by 
boiling at 95°C for 10 min in 25 μl of 3 x SDS-loading buffer, separated by 
10% SDS-PAGE and analyzed by Western blotting with anti-RAD51 antibody 
and anti-omni-probe antibody. 
 
Western blot analysis 
Proteins separated by 10% SDS-PAGE were transferred to Hybond-P PVDF 
membrane (GE Healthcare) according to standard protocols. To check the 
transfer, the membrane was stained with Ponceau dye. The membrane was 
blocked with 5% non-fat dry milk in TBS-T [20 mM Tris-HCl (pH 7.4), 150 mM 
NaCl, 0.1% (v/v) Tween-20] for 1-2 h at RT and probed with primary antibody 
overnight at 4°C in 5% non-fat dry milk in TBS-T. The membrane was 
afterward washed three times with TBS-T for 20 min at RT, incubated with 
corresponding horseradish peroxidase (HRP) coupled secondary antibody for 
1 h at RT in 2.5% non-fat dry milk in TBS-T, followed three additional washing 
steps with TBS-T. Immune complexes were detected using enhanced 
chemiluminescence (ECL) reagent (GE Healthcare). The primary antibodies 
used were: rabbit polyclonal anti-RAD51 antibody (BD Pharmingen Cat. No. 
551922), 1:5000; mouse monoclonal anti-RAD51 antibody ab1837 (Abcam), 
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1:500; goat polyclonal anti-omni-probe antibody sc-499-G (Santa Cruz 
Biotechnology), 1:1000. Additionally, the following HRP coupled secondary 
antibodies were used: sheep anti-mouse IgG (GE Healthcare NA931V); 
donkey anti-rabbit IgG (GE Healthcare NA934V); bovine anti-goat IgG sc-
2350 (Santa Cruz Biotechnology). 
 
DNA for enzyme assays 
Bacteriophage M13mp8.32 ssDNA (116) was prepared as described above. 
 To generate topologically relaxed dsDNA plasmid, 4 μg of supercoiled 
pGEM-7Zf(+) DNA (Promega) were incubated with 2 μl E. coli Topoisomerase 
I (0.8 mg/ml) at 37°C for 30 min in 40 μl buffer R supplemented with 100 
μg/ml BSA, followed by heat inactivation of the enzyme (65°C for 10 min). 
 
RAD51 filament-dissociation assay 
To measure displacement of RAD51 from ssDNA, a previously described 
topoisomerase-linked RAD51-trap assay (165,169) was adapted. Reactions 
were carried out at 37°C in an end-volume of 25 μl of buffer R [25 mM Tris-
HCl (pH 7.5), 1 mM MgCl2, 50 mM KCl, 1 mM DTT] supplemented with 100 
μg/ml BSA, 2 mM ATP and an ATP-regenerating system consisting of 10 U/ml 
creatine phosphokinase (SIGMA, C3755) and 12 mM phosphocreatine 
(SIGMA, P7936). Indicated concentration of RAD51 or RAD51K133R was 
pre-incubated with circular M13mp8.32 ssDNA (9 μM nt) for 6 min, followed 
by addition of indicated concentrations of RECQ5 variants, BLM core, or 
BLM:RECQ5 and typically 150 nM RPA. After a 6-min incubation, 
topologically relaxed pGEM-7Zf(+) DNA (7 μM bp) and indicated 
concentrations of wheat germ topoisomerase I were added to complete the 
reaction. The reaction was incubated for additional 8 min and then terminated 
by the addition of 1% SDS, 12 mM EDTA, and 1 mg/ml proteinase K followed 
by a 25-min incubation at 37°C. DNA products were resolved by 1% agarose 
gel electrophoresis in 0.5 x TBE buffer at 100V for 2 h, stained in EtBr solution 
(0.5 μg/ml) and visualized on a UV transilluminator. Gel images were 
quantified using IMAGEQUANT software. The relative concentration of 
supercoiled dsDNA was expressed as percentage of total dsDNA. The values 
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for relaxed dsDNA were corrected using a factor of [dsDNA sc in positive 
control]/[ds DNA rel in negative control]. In the agarose gels shown, this 
corresponds to dsDNA bands in lane 3 / 4. 
 
ATPase assay 
ATPase activity of RECQ5 variants, BLM core or BLM:RECQ5 chimera was 
measured in the presence of saturating concentrations of ssDNA. The 
reactions were carried out at 37°C for 30 min with 20 nM enzyme, 25 μg/ml 
M13mp8.32 ssDNA in 20 μl of buffer R supplemented with 50 μg/ml BSA and 
2 mM ATP. The reactions were terminated by addition of 20 μl of 0.1 M EDTA 
(pH 8). The amount of inorganic phosphate (Pi) released by ATP hydrolysis 
was determined by a colorimetric assay using malachite green (281,282). 
Briefly, 10 μl of stopped reaction mixture was added to 30 μl of 0.1 M EDTA 
(pH 8) in a 96-well microplate. To that mixture, 100 μl of freshly diluted 5.72% 
(w/v) ammonium molybdate/6 M HCl in H20 (ratio 1:3) and 50 μl malachite 
green [0.0812% (w/v) in water] was added and incubated for a few minutes 
before absorbance at 620 nm was measured in a microplate reader 
(Molecular devices). The concetration of Pi released by ATP hydrolysis was 
determined from a calibration curve derived from solutions of known Pi 
concentration (KH2PO4). Reactions for individual proteins were done in 
triplicates. 
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